Document:

Exhibit 4.2

 

POET TECHNOLOGIES
INC. (the “Company”)

Suite
1107, 120 Eglinton Avenue East, Toronto, Ontario, Canada M4P 1E2

Facsimile:
(416) 322-5075       Telephone: (416) 368-9411

 

 

INFORMATION CIRCULAR

(As at May 24, 2016 except as indicated)

 

The Company is providing this Information Circular
in connection with the solicitation of proxies by the management (“Management”) of the Company for use at the annual
general meeting (the "Meeting") of the shareholders of the Company to be held at 10:00 a.m. (PDT) on July 7, 2016 and
for the purposes set forth in the Notice of Annual General Meeting. It is expected that the solicitation of proxies will be primarily
by mail or by “Notice and Access” to electronic materials available on the internet; however, proxies may also be solicited
by directors, officers and certain employees of the Company, without receiving special compensation, by telephone, facsimile (“fax”)
or by other personal contact. The cost of solicitation of proxies by Management will be borne by the Company.

 

The Company may pay the reasonable costs incurred by
persons who are shareholders but not the beneficial owners of common shares of the Company (“Shares”) (such as brokers,
dealers and other registrants under applicable securities law and nominees and custodians) in sending or delivering copies of the
Notice of Meeting, the Management Information Circular, the form of proxy (the “Proxy”) and/or the voting instruction
form (the “VIF”) to the beneficial owners. However any such payments must be pre- approved by the Company. The Company
will furnish to such persons, upon request to the Secretary of the Company, and without additional cost, additional copies of the
Notice of Meeting, the Management Information Circular, and the Proxy and/or the VIF.

 

NOTICE AND ACCESS

 

In accordance with the Notice and Access rules adopted
by the Ontario Securities Commission under NI 54-101, the Company is sending its proxy-related materials (the “Proxy Materials”)
to shareholders using the Notice and Access method. Therefore, although shareholders will still receive the Proxy and/or VIF in
paper copy, the additional Proxy Materials, including this Management Information Circular, the Notice of Meeting, the Annual Report
(containing the annual audited consolidated financial statements and related MD&A) will not be physically delivered. Instead,
shareholders may access or download the Proxy Materials from the Company's website at www.poet-technologies.com/agm
or may also access them from SEDAR at www.sedar.com under the Company's filed documents.
The Company believes that this delivery method will expedite the receipt of the Proxy Materials by shareholders, reduce its printing
and mailing expenses and reduce the environmental impact of disposing of the Proxy Materials after they are no longer useful.

 

Registered holders or beneficial owners may request
paper copies of the Notice and Management Information Circular booklet be sent to them by postal delivery at no cost to them. Requests
may be made up to one year from the date the Proxy Materials are posted on the Company's website. In order to receive a paper copy
of the Proxy Materials or if you have questions concerning Notice and Access, please contact the Secretary of the Company, by telephone
at 416-862-7330 or by e-mail at agm@poet- technologies.com or
call the Company’s registrar and transfer agent, TMX Equity Transfer Services Inc. (“TMX Equity”) at 1-866-393-4891.

 

The purpose of the Proxy and/or VIF which were mailed
to shareholders is to designate persons who will vote the Proxy on a shareholder’s behalf in accordance with the instructions
given by the shareholder in the said form.

 

VOTING PROCESS – REGISTERED SHAREHOLDERS

 

Appointment of Proxies

 

The persons named in the Proxy are officers and/or directors
of the Company (the “Management Proxyholders”). A registered shareholder can appoint a person other than the Management
Proxyholders,

 

    	 	- 1 -	 

    

    

who need not be a shareholder, to represent him or her
at the Meeting by inserting such person’s name in the blank space provided in the Proxy or by completing another form of
proxy.

 

A registered shareholder appointing a proxyholder may
indicate the manner in which the appointed proxyholder can vote with respect to any specific item by checking the space opposite
the item on the Proxy. If the shareholder giving the Proxy wishes to confer a discretionary authority with respect to any item
of business, then the space opposite the item should be left blank. The Shares represented by the Proxy submitted by a shareholder
will be voted or withheld from voting in accordance with the directions, if any, given in the Proxy.

 

If a shareholder does not specify
a choice and the shareholder has appointed one of the Management Proxyholders as proxyholder, the Management Proxyholders will
vote in favour of the matters specified in the Notice of Meeting and in favour of all other matters proposed by Management at the
Meeting.

 

Voting Shares by Proxy

 

Registered shareholders at the close of business on May
27, 2016 may vote their proxies as follows:

 

Internet voting: Go to the website indicated
on the Proxy (http://www.voteproxyonline.com) and follow the instructions on the screen. To appoint
a proxyholder, other than Management Proxyholders, to represent you at the Meeting, inserting such person’s name in the blank
space provided on the online Proxy. Then complete your voting instructions and submit the form. The time and date submitted will
automatically be recorded.

 

Voting by mail or fax: Complete the Proxy
in a legible manner. To appoint a proxyholder, other than the Management Proxyholders, to represent you at the Meeting, insert
such person’s name in the blank space provided in the Proxy. Complete your voting instructions by checking the appropriate
boxes on the Proxy, date and sign the form. You may either send the completed Proxy to TMX Equity by mail or by fax. Do not
send by both methods. The address is Suite 300, 200 University Avenue, Toronto, Ontario M5H 4H1 and the fax number is 416-595-9593.

 

Deadline for Receipt of Proxies

 

The deadline for receiving duly completed and executed
forms of proxy or submitting your proxy by fax or over the internet is 1:00 p.m. (EDT) on May 27, 2016, or no later than 48 hours
(excluding Saturdays, Sundays and holidays) before the time of any adjourned or postponed Meeting. A registered shareholder
attending the Meeting has the right to vote in person, but he must, before the start of the Meeting, register with the scrutineer
of the Meeting. If he had previously submitted a Proxy, he must specifically request that his proxy be nullified with respect to
the matters and any subsequent matters thereafter to be voted upon at the Meeting or any adjournment or postponement thereof, thereby
permitting him to vote in person. Notwithstanding the foregoing, the Chair of the Meeting has the sole discretion to accept proxies
received after such deadline but is under no obligation to do so.

 

Revocation of Proxies

 

A proxy submitted pursuant to this solicitation may be
revoked in any manner permitted by law and by written notice, signed by the shareholder or by the shareholder’s attorney
authorized in writing (or, if the shareholder is a corporation, by a duly authorized officer or attorney), and deposited with the
Company’s transfer agent, TMX Equity, Suite 300, 200 University Avenue, Toronto, Ontario M5H 4H1, at any time up to and including
the last business day preceding the date of the Meeting, or any adjournment or postponement thereof, at which the proxy is to be
used.

 

A proxy submitted pursuant to this solicitation may
also be revoked prior to the commencement of voting by attending the Meeting in person and registering with the scrutineer as a
registered shareholder personally present and requesting to nullify his proxy to allow him to vote in person.

A revocation of proxy does not affect any matter on which
a vote has been taken before the revocation.

 

    	 	- 2 -	 

    

    

Exercise of Discretion by Proxies

 

The persons named in the enclosed Proxy will vote the
Shares in respect of which they are appointed in accordance with the direction of the shareholders appointing them. In the absence
of such direction, the relevant Shares will be voted in favour of the passing of all the resolutions described below.

The enclosed Proxy confers discretionary authority
on the persons named in the Proxy with respect to amendments or variations to matters identified in the Notice of Meeting and with
respect to other matters which may properly come before the Meeting. At the time of printing of this Circular, Management knows
of no such amendments, variations or other matters to come before the Meeting. However, if amendments or variations to any other
matters which are not now known to Management should properly come before the Meeting, the Proxy will be voted on such matters
in accordance with the best judgment of the named proxyholder.

 

VOTING PROCESS – NON-REGISTERED
SHAREHOLDERS

 

Only registered shareholders of the Company or the persons
they appoint as their proxyholders are permitted to vote at the Meeting. Many shareholders of the Company are referred to as “non-registered”
shareholders (“Non-Registered Shareholders”) because the Shares they own are not registered in their names but are
instead registered in the name of the brokerage firm, bank or trust company through which they purchased the Shares. Shares held
by brokers or their agents or nominees can only be voted (for or against resolutions) upon the instructions of the Non-Registered
Shareholder. Without specific instructions, a broker and its agents and nominees are prohibited from voting Shares for their clients.
Therefore, Non-Registered Shareholders should ensure that instructions respecting the voting of their Shares are communicated to
the appropriate person or that the Shares are duly registered in their name.

 

Applicable regulatory policy requires intermediaries/brokers
to seek voting instructions from Non- Registered Shareholders in advance of shareholders’ meetings. Every intermediary/broker
has its own mailing procedures and provides its own forms and voting instructions to clients, which should be carefully followed
by Non-Registered Shareholders in order to ensure that their Shares are voted at the Meeting. Shares beneficially owned by a Non-Registered
Shareholder are registered either:

 

	 	i)	in the name of an intermediary
    (“Intermediary”) that the Non-Registered Shareholder deals with in respect of the Shares of the Company (Intermediaries
    include, amongst others, banks, trust companies, securities dealers or brokers, and trustees or administrators of self-administered
    RRSPs, RRIFs, RESPs and similar plans); or
	 	 	 
	 	ii)	in the name of a clearing agency (such as CDS
    Clearing and Depository Services Inc. in Canada or The Depository Trust & Clearing Corporation in the United States) of
    which the Intermediary is a participant.

 

Unless you have previously informed your Intermediary/broker
that you do not wish to receive material relating to the Meeting, you should have received a Proxy or a VIF. In either case you
have the right to exercise voting rights attached to the Company’s Shares beneficially owned by you, including the right
to attend and vote the Shares directly at the Meeting, assuming that you follow the instructions contained in the said Proxy
or VIF.

 

The documents that you receive and from whom you receive
them will vary depending upon whether you are a "non-objecting beneficial owner" ("NOBO") residing in Canada,
which means you have provided instructions to your Intermediary that you do not object to the disclosure of the beneficial ownership
information about you to the Company, or an "objecting beneficial owner" ("OBO") residing in Canada, which
means that you have objected to the disclosure of such beneficial ownership information about you to the Company, or a non-registered
shareholder residing outside of Canada (the “Other Non-Registered Shareholders”).

 

NOBO Shareholders

 

TMX Equity is handling the mailing to NOBO’s in
addition to mailing to the Registered Shareholders. All NOBO Shareholders of the Company will receive a VIF from TMX Equity.

 

If you are a NOBO shareholder of the Company, and TMX
Equity has sent a VIF directly to you, your name and address and information about your holdings of Shares of the Company have
been obtained in

 

    	 	- 3 -	 

    

    

accordance with applicable securities regulatory requirements
from the intermediary/broker holding Shares on your behalf. By choosing to send the VIF to you directly, the Company has assumed
responsibility for (i) delivering the VIF to you, and (ii) executing your proper voting instructions.

 

Therefore a NOBO Shareholder of the Company can vote
the Shares represented by his VIF in a similar manner as registered shareholders. The process to vote a VIF or to appoint a proxyholder
are the same as that described under “Voting Process – Registered Shareholders”, except that:

 

	 	 •	the form
    received by him is a VIF instead of a Proxy; and
	 	 	 
	 	 •	a NOBO shareholder
    cannot attend the Meeting to vote in person unless, at least 48 hours (excluding Saturdays, Sundays and holidays) before the
    Meeting, he appoints himself as a proxyholder according to the instructions provided on the VIF and registers with the scrutineer
    upon arriving at the Meeting.

 

OBO Shareholders

 

In accordance with applicable securities law requirements,
the Company will upon request distribute copies of the Proxy Materials to the clearing agencies and intermediaries for distribution
to OBO Shareholders and to the Other Non-Registered Shareholders. Intermediaries are required to forward the Proxy Materials to
Non-Registered Shareholders unless a Non-Registered Shareholder has waived the right to receive them. Intermediaries often use
service companies to forward the Proxy Materials to Non- Registered Shareholders. Generally, Non-Registered Shareholders who have
not waived the right to receive Proxy Materials will either:

 

	 	 •	be given a VIF which is not signed by the Intermediary and which, when properly completed and signed by the Non-Registered Shareholder and returned to the Intermediary or its service company, will constitute voting instructions which the Intermediary must follow. Typically, this VIF will consist of a one page pre-printed form; or
	 	 	 
	 	 •	be given a Proxy which has already been signed by the Intermediary (typically by a facsimile, stamped signature), which is restricted as to the number of Shares beneficially owned by the OBO shareholder but which is otherwise not completed by the Intermediary. Because the Intermediary has already signed the Proxy, the signature of the OBO shareholder is not required when submitting the Proxy.

 

In either case, the purpose of these procedures is
to permit Non-Registered Shareholders to direct the voting of the Shares of the Company that they beneficially own. Since only
registered shareholders and their proxyholders may attend and vote at the Meeting, if a Non-Registered Shareholder attends the
Meeting, the Company will have no record of the Non-Registered Shareholder’s shareholding or of his/her or its entitlement
to vote unless the Non-Registered Shareholder’s nominee has appointed the Non- Registered Shareholder as proxyholder. Therefore,
a Non-Registered Shareholder who receives one of the above forms and wishes to vote at the Meeting in person (or have another person
attend and vote on behalf of the Non-Registered Shareholder), the Non-Registered Shareholder should insert the Non- Registered
Shareholder’s name or such other person’s name in the blank space provided, and depending on the design of the VIF,
may need to strike out the names of the Management Proxyholders listed therein. The voting instructions given to the Non-Registered
Shareholder, may provide for voting by telephone, on the Internet, by mail or by fax. In either case, Non-Registered Shareholders
should carefully follow the instructions of their Intermediary, including those regarding when and where the Proxy or VIF is to
be delivered.

 

A Non-Registered Shareholder, who has submitted a Proxy,
may revoke it by contacting the Intermediary through which the Non-Registered Shareholder’s Shares are held and following
the instructions of the Intermediary respecting the revocation of proxies. This procedure should be initiated sufficiently in advance
of the Meeting to ensure there is sufficient time to implement your instructions.

 

In all cases it is important that the Proxy or VIF be
received by the Intermediary or its agent sufficiently in advance of the deadline set forth in the Notice of Meeting to enable
the Intermediary or its agent to provide voting instructions on your behalf before the deadline.

Failing to follow the proper voting instructions described
in the VIF may invalidate your vote and/or not allow you attend and vote in person at the Meeting.

 

    	 	- 4 -	 

    

    

VOTING SHARES AND PRINCIPAL HOLDERS THEREOF

 

The Company is authorized to issue unlimited Shares
without par value, of which 217,758,337 shares are issued and outstanding as at May 24, 2016. The Company has fixed the close of
business on May 27, 2016 as the record date (the “Record Date”) for the purpose of determining shareholders entitled
to receive notice of and vote at the Meeting. In accordance with the provisions of the Business Corporations Act (Ontario),
the Company has prepared a list of shareholders on the Record Date. Each shareholder is entitled to one vote for each share held
in respect to each matter to be voted at the Meeting. Only shareholders of record on the Record Date are entitled to vote at the
Meeting.

 

To the knowledge of the directors and officers of the
Company, no person beneficially owns, directly or indirectly, or controls or directs shares carrying 10% or more of the voting
rights attached to all shares of the Company.

 

 

ELECTION OF DIRECTORS

 

The directors of the Company are elected at each
annual general meeting and hold office until the next annual general meeting or until their successors are appointed. In the absence
of instructions to the contrary, the enclosed Proxy will be voted for the nominees herein listed.

 

The Company is required to have an audit committee.
Members of the audit committee and other committees of the Board of Directors of the Company (the “Board”) are as set
out in the table below.

 

The
number of directors of the Company to be elected at the Meeting is seven. Management of the Company proposes to nominate each of
the following persons for election as a director. Information concerning such persons, as furnished by the individual nominees,
is as follows:

 

 

	
Name, Jurisdiction of Residence and Position	
        Principal Occupation or employment and, if
        not a previously elected Director, occupation during the past 5 years	Date First Elected or Appointed as a Director	Number
    of Common Shares beneficially owned, directly or indirectly, or controlled or directed (4)
	
        Todd A. DeBonis (2)

        Aptos, CA, USA
	President and CEO of Pixelworks, Inc. (NASDAQ: PXLW) since January 2016; Vice President of Global Sales and Strategic Development at TriQuint Semiconductor from April 2004 to February 2015.	April 7, 2015	nil
	
        David E. Lazovsky (1)

        Los Gatos, CA, USA
	President and Chief Executive Officer of Intermolecular (NASDAQ: IMI) from September 2004 to October 2014.	April 7, 2015	nil
	
        Ajit Manocha (2)(3)

        Los Gatos,CA, USA
	
        Executive Co-Chairman of the Company since November 17, 2014;
        Executive Vice-Chairman from July 7 to November 17, 2014; Chief Executive Officer of Global Foundries from June 2011 to
        Jan. 2014, from March 2009 to May2011, he served on the boards of Maskless Lithography, SVTC Technologies and Signet
        Solar and was advisor to Philips Lumileds, ASE, SOITEC and ATIC.
	July 7, 2014	nil
	
        John F. O’Donnell (2) (3)

        Toronto, ON, Canada
	Independent lawyer practising in Toronto, Ontario since 1973 (currently counsel to Stikeman Keeley Spiegel Pasternack LLP).	
        February 14,

        2012
	30,000
	
        Chris Tsiofas (1) (2) (3)

        Toronto, ON, Canada
	Partner with Chartered Accountancy firm of Myers Tsiofas Norheim LLP since 1994.	
        August 21,

        2012
	25,000

 

    	 	- 5 -	 

    

    

	Name, Jurisdiction of Residence and Position	Principal Occupation or employment and, if
        not a previously elected Director, occupation during the past 5 years	Date First Elected or Appointed as a Director	
        Number of Common Shares beneficially owned,
        directly

        or indirectly, or controlled or directed (4)

	Suresh Venkatesan Los Gatos, CA, U.S.A.	CEO of the Company since June 11, 2015. Previously, Senior Vice President, Technology Department at Global Foundries	June 11, 2015	40,000
	
        Mohandas Warrior (1)

        Palo Alto, CA, U.S.A.
	President and Chief Executive Officer of Alfalight Inc.since February 2004.	June 15, 2015	nil

 

(1)   
Current Member of the Audit Committee.

(2)   
Current Member of Compensation Committee.

(3)   
Current Member of Corporate Governance and Nominating Committee.

(4)   
Shares beneficially owned, directly or indirectly, or over which control or direction is exercised, as at May 24, 2016, based
upon information filed on SEDI by the individual directors or furnished to the Company by them. Unless otherwise indicated, such
shares are held directly.

 

The following briefly describes the qualification and experience
of the nominees to the Board:

 

Todd A. DeBonis – Mr. DeBonis
is a veteran semiconductor executive with over 27 years of expertise in sales, marketing and corporate development. He is currently
President and CEO of Pixelworks, Inc., having joined the company in January 2016. For the last decade prior to that, Mr. DeBonis
was the Vice President of Global Sales and Strategic Development at TriQuint Semiconductor, Inc. Mr. DeBonis played an integral
part in the recent merger with RF Micro Devices, Inc. and subsequent creation of Qorvo, Inc. (NASDAQ: QRVO). Mr. DeBonis previously
held the position of Vice President, Worldwide Sales and Marketing at Centillium Communications. Mr. DeBonis also served as the
Vice President, Worldwide Sales for Ishoni Networks and Vice President, Sales & Marketing for the Communications Division of
Infineon Technologies North America. Mr. DeBonis has a B.S. degree in Electrical Engineering from the University of Nevada.

 

David E. Lazovsky – Mr. Lazovsky
is the founder of Intermolecular, Inc. (NASDAQ: IMI) and served as the Company's President and Chief Executive Officer and as a
member of the Board of Directors from September 2004 to October 2014. Mr. Lazovsky has an in-depth knowledge of the semiconductor
industry, technology and markets. Prior to founding Intermolecular, Mr. Lazovsky held several senior management positions at Applied
Materials Inc. (NASDAQ: AMAT). From 1996 through August 2004, Mr. Lazovsky held management positions in the Metal Deposition and
Thin Films Product Business Group where he was responsible for managing more than $1 billion in Applied Materials' semiconductor
manufacturing equipment business. From 2003 until 2004, Mr. Lazovsky managed key strategic accounts in Business Management where
he worked closely with leading integrated circuit manufacturers to ensure Applied Materials was developing and providing cutting-edge
technology solutions. From 2002 until 2003, Mr. Lazovsky served as the Technology Program Manager for the Endura 2 Platform, Applied
Materials' flagship 300mm metal deposition platform. From 2000 until 2002, Mr. Lazovsky was based in Grenoble, France and served
as Director of Business Management for the European region in the Metal Deposition Product Business Group. Previously, Mr. Lazovsky
served as a Business Manager from 1997 to 2000, Account Product Manager from 1995 to 1997. Mr. Lazovsky holds a B.S. in mechanical
engineering from Ohio University and, as of March 31, 2014, held 41 pending or issued U.S. patents.

 

Ajit Manocha – Mr. Manocha has
over 35 years of experience in the semiconductor industry with deep knowledge of semiconductor technology and operations. He has
worked in all aspects of the business including research, applied development, manufacturing, worldwide sales, global supply chain
and IT, and his most recent role was as CEO of GlobalFoundries from June 2011 to January 2014. He has a wealth of experience by
working in companies like AT&T, Bell Labs/Microelectronics, Philips Semiconductors (now known as NXP), Spansion, and GlobalFoundries.
He has managed at various executive levels and successfully led organizations of various sizes ranging from very small organizations
with fewer than 15 people to very large organizations with well over 25,000 people. He has also served on various boards as director
and chairman. He is currently representing GlobalFoundries on the

 

    	 	- 6 -	 

    

    

Semiconductor Industry Association Board and is also
serving on the U.S. Presidential Committee for Advanced Manufacturing Partnership.

 

John F. O’Donnell – Mr. O’Donnell
has a BA (Economics) and an LLB. He has practiced law in the City of Toronto since 1973 and has been on the Board of Directors
of the Company since February 2012. He is currently counsel to Stikeman Keeley Spiegel Pasternack LLP. His practice is primarily
in the field of corporate and securities law and, as such, he is and has been counsel to several publicly traded companies. Mr.
O’Donnell is currently also Chairman of the Board of Montana Gold Mining Company Inc. (CSE: MGM).

 

Chris Tsiofas – Mr. Tsiofas is
a Chartered Accountant (CA) and a Chartered Professional Accountant (CPA). He earned a Bachelor of Commerce Degree from the University
of Toronto in 1991 and has been a member of the Institute of Chartered Accountants of Ontario since 1993. He has been on the Board
of Directors since August 2012. He is a partner with the Toronto Chartered Accountancy firm of Myers Tsiofas Norheim LLP, a position
he has held since 1994.

 

Dr. Suresh Venkatesan – Dr. Venkatesan
was most recently Senior Vice-President, Technology Development at Global Foundries and was responsible for the Company’s
Technology Research and Development. Dr. Venkatesan joined Global Foundries in 2009, where he led the development and ramp up of
the 28nm node and was instrumental in the technology transfer and qualification of 14nm. In addition, he was responsible for the
qualification and ramp up of multiple mainstream value added technology nodes.

 

Mr. Mohandas Warrior – Mohan has
been the President & CEO of Alfalight, Inc. since 2004 – a high power diode laser company which serves military and industrial
customers. Mohan is a 30+ year semiconductor industry veteran with 15 years of experience at Motorola Semiconductors where he held
senior executive responsibilities in engineering and operations. Following Motorola, he successfully launched two venture-backed
companies in Austin, Texas. He was a founding charter member of the Austin chapter of TiE and served on the Texas Higher Education
Panel. He has also served on the Electronics Materials panel of the National Science Foundation and has been an invited speaker/panelist
to many semiconductor forums. He serves on the Boards of several opto-electronic and technology companies. Mohan’s academic
credentials include a BS in Chemical Engineering from IIT Delhi, a MS in Chemical Engineering from Syracuse University and an MBA
from the Kellogg School of Management at Northwestern University.

 

No proposed director is to be elected under any arrangement
or understanding between the proposed director and any other person or company, except the directors and executive officers of
the company acting solely in such capacity.

 

To the knowledge of the Company, no proposed director:

 

	 	(a)	is, as at the date of the Information Circular, or has been, within 10 years before the date of the Information Circular, a director, chief executive officer ("CEO") or chief financial officer ("CFO") of any company (including the Company) that, while that person was acting in that capacity:
	 	 	 
	 	 	(i)	was the subject, while the proposed director was acting in the capacity as director, CEO or CFO of such company, of a cease trade or similar order or an order that denied the relevant company access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days; or
	 	 	 	 
	 	 	(ii)	was subject to a cease trade or similar order or an order that denied the relevant company access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days, that was issued after the proposed director ceased to be a director, CEO or CFO but which resulted from an event that occurred while the proposed director was acting in the capacity as director, CEO or CFO of such company; or
	 	 	 	 
	 	(b)	 is, as at the date of this Information Circular, or has been within 10 years before the date of the Information Circular, a director or executive officer of any company (including the Company) that, while that person was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets; or

 

    	 	- 7 -	 

    

    

 

	 	(c)	has, within
    the 10 years before the date of this Information Circular, become bankrupt, made a proposal under any legislation relating
    to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors,
    or had a receiver, receiver manager or trustee appointed to hold the assets of the proposed director;
	 	 	 
	 	(d)	has been subject to
    any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or
    has entered into a settlement agreement with a securities regulatory authority; or
	 	 	 
	 	(e)	has been subject to
    any penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable
    securityholder in deciding whether to vote for a proposed director.

 

The following directors of the Company hold directorships in other reporting
issuers as set out below:

 

	Name of Director	Name of Other Reporting Issuer
	John F. O’Donnell	Montana Gold Mining Company Inc. (CSE: MGM)
	Todd A. DeBonis	Pixelworks, Inc. (NASDAQ: PXLW)

 

If there are more nominees for election as directors
than there are vacancies to fill, those nominees receiving the greatest number of votes will be elected or appointed, as the case
may be, until all such vacancies have been filled. If the number of nominees for election or appointment is equal to the number
of vacancies to be filled, all such nominees will be declared elected or appointed by acclamation.

 

The Board has adopted a policy for majority voting
for individual directors (“Majority Voting Policy”). Under the Majority Voting Policy, the Proxy for any shareholders
meeting where directors are to be elected will enable each shareholder to vote for, or withhold from voting on, each director
nominee (the “Nominee” or collectively the “Nominees”) separately. If votes “for” the election
of a Nominee are fewer than the number voted “withheld”, the Nominee is expected to submit his or her resignation
promptly after the meeting of shareholders for the consideration of the Corporate Governance and Nomination Committee (the “CGN
Committee”). The CGN Committee will make a recommendation to the Board after reviewing the matter, and the Board will then
decide whether to accept or reject the resignation. The Board’s decision to accept or reject the resignation will be disclosed
to shareholders. The Nominee will not participate in any CGN Committee or Board deliberations as to whether to accept or reject
the resignation. The Majority Voting Policy does not apply in circumstances involving contested director elections. 

 

EXECUTIVE COMPENSATION

 

A)    
Compensation Discussion and Analysis

 

The purpose of this Compensation Discussion and Analysis
(“CD&A”) is to provide information about the Company’s executive compensation objectives and processes and
to discuss compensation decisions relating to the Company’s senior officers in 2015.

 

DESCRIPTION AND EXPLANATION OF ELEMENTS OF COMPENSATION PROGRAM

 

(i)     
The objectives of the Company’s executive compensation program are:

•    
to attract, retain and motivate quality executives; 

•    
to align the interests of executives with those of the Company’s shareholders;

•    
to provide total compensation to executives that is competitive with that paid by other companies of comparable size
engaged in similar business in appropriate regions;

•    
to evaluate executive performance on the basis of targets determined by the Board;

•    
to be cognizant of expense management in determination of compensation rewards.

 

(ii)    
The executive compensation program has been designed to reward executives for:

•    
the reinforcement of the Company’s business objectives and values;

•   
the attainment of key research and financial milestones dependant on the executive; and their individual performance
and significant achievements.

 

(iii)  
 The executive compensation program consists of the following elements: base salary, variable pay compensation and stock
option incentives.

    	 	- 8 -	 

    

    

 

(iv)    
In addition to his or her fixed base salary, each officer may be eligible to receive variable pay compensation or bonus
meant to motivate him or her to achieve short-term goals. Currently, the Company does not have in place established procedures
for determining variable pay compensation. Stock options are a very important element of the variable pay compensation and do not
require cash disbursement from the Company. Stock options are also generally awarded to officers and consultants at the time of
hire and are used as a recruitment tool to attract highly qualified and experienced executives and consultants to the Company.
Stock options are also granted at other times during the year. As the Company is still continuing to develop its POET Technology,
it must conserve its limited financial resources and control costs to ensure that funds are available when needed to complete its
scheduled developments. As a result, the Board has to consider not only the financial situation of the Company at the time of the
determination of the compensation, but also the estimated financial situation in the mid and long term. Also the granting of stock
options aligns officers’ rewards with an increase in shareholder value over the long term. The use of stock options encourages
and rewards performance by aligning an increase in each officer’s compensation with increases in the Company’s performance
and in the value of the shareholders’ investments.

 

(v)     
Determination of the Amount of Each Compensation Program Element - In order to assist the Board in fulfilling its oversight
responsibilities with respect to human resources matters, the Board established a Compensation Committee. The Compensation Committee
reviews and makes determinations with respect to senior officer compensation on a regular basis with any discretionary compensation
used only for extraordinary projects or significant milestone results that advance the Company’s growth potential. When determining
officer’s compensation, the Compensation Committee receives input from the Chairmen of the Board, and the Chief Executive
Officer of the Company. The Compensation Committee has engaged Compensia to conduct a Peer Group review that was prepared with
the input of the CEO. A draft Peer Group was circulated and the CEO felt it was appropriate. Compensia has given guidance to the
Compensation Committee with respect to appropriate comparative terms for its incentive stock option plan and a salary review of
various positions relative to the Peer Group. The Compensation Committee will utilize the comparative reviews to assist in making
appropriate recommendations.

 

Base Salary -
The base salary for officers, is reviewed by the Compensation Committee of the Board, within a reasonable time prior to the expiry
of the current employment or consulting agreement, with input and direction being provided by the Chairmen of the Board, and the
Chief Executive Officer of the Company. The base salary review takes into consideration the current competitive market conditions,
experience, proven and/or expected performance, and the particular skills of the officer.

 

For more information on salaries
paid to the executives, refer to the Summary Compensation Table.

 

Variable Pay Compensation – The
Company has no current procedure to assess each officer’s role in adding to the Company’s growth. However, there are
occasions when there can be significant officer achievements that further the business potential of the Company or create vital
successes to the Company. Therefore, there are times when a discretionary variable pay award may be made to an officer. This type
of payment is done after presenting the achievement to the Compensation Committee. If deemed important to the success of POET’s
business, the Committee can approve such an ad hoc variable payment. Stock Options are a non-cash component of the Variable Pay
Compensation and are discussed below.

 

Stock Options - The Board, based
on recommendations of the Compensation Committee where appropriate, makes the following determinations:

 

•   
it selects officers and other persons who are entitled to participate in the Stock Option Plan;

•   
it determines the number of options granted to such individuals;

•   
it determines the date on which each option is granted and the corresponding exercise price; and

    	 	- 9 -	 

    

    

 

•   
it determines the vesting schedule for the stock options granted.

 

The Board makes these determinations subject to the provisions of the
existing Stock Option Plan. For more information refer to the section entitled “B) Option-Based Awards”.

 

(vi)    
Each element of the compensation program has been designed to meet one or more objectives of the overall executive compensation
plan. The fixed base salary of each officer, combined with the variable pay compensation and stock options, has been designed to
provide the total compensation package which the Board believes is reasonably competitive with that provided by other companies
in the peer group and others of comparable size engaged in similar business in appropriate regions. In addition, the variable pay
compensation has been designed to align the interests of executives with those of the Company’s shareholders and to evaluate
financial performance on basis of relevant technical or financial milestones. Option grants are designed to align executives’
and shareholders’ interests and to provide longer term compensation incentives.

 

REVIEW AND APPROVAL

 

The Compensation Committee of the Board is responsible
for making recommendations for approval by the Board with respect to remuneration of executives of the Company including the Chief
Executive Officer of the Company and senior officers of the Company. All executive compensation components are reviewed by the
Compensation Committee as needed and its recommendations are subject to approval of the Board, as appropriate.

 

B)    
Option-Based Awards

 

The Company’s stock option plan has been and
will be used to provide share purchase options which are granted in consideration of the level of responsibility of the executive
as well as his or her impact or contribution to the longer-term operating performance of the Company. In determining the number
of options to be granted to the executive officers, the Compensation Committee and the Board take into account the number of options,
if any, previously granted to each executive officer, and the exercise price of any outstanding options. With these guidelines,
the Board ensures that such new grants are in accordance with the policies of the TSX Venture Exchange (“TSXV”), and
closely align the interests of the executive officers with the interests of shareholders.

 

The exercise of options by an Optionee, who is an
officer, employee or director of the Company, will generally create an immediate tax liability to the Optionee as follows:

 

•   
If the said Optionee resides in Canada, he will be deemed, whether or not the shares were sold, to have received
an employment income equal to the value of the option exercised and will be required to pay the Company, in addition to the cost
of exercise, an amount equal to the tax liability of the deemed employment income, in order for the Company to remit withholding
taxes to Canada Revenue Agency following the exercise. Subsequent capital gains or losses will be calculated based on the market
price on the day of exercise, but capital losses cannot offset the deemed employment income.

 

•   
If the said Optionee resides in the USA, he will be required, for the tax year of the exercise, to pay income tax
on the value of the option exercised, equal to the amount of short-term or long- term Capital Gain tax rates when the shares are
sold, or if applicable, according to Alternative Minimum Tax rates. Depending on the circumstances, the Company may be required
to collect from the said Optionee, a withholding tax in order for the Company to remit to the IRS following the exercise.

 

Optionees can exercise their options at any time
at their discretion, and, except for times when the officers, directors and employees are prohibited from trading under the corporate
governance policies of the Company (when the “Trading Window” is closed), are also free to sell their shares acquired
through exercising their options at any time at their discretion, subject to notification to Management. Options exercised while
the Trading Window is closed can only be sold after the Trading Window reopens. The Company has entered into an agreement with
Solium Capital Inc. to provide a broker assisted exercise program for Optionees under the Company’s Stock Option Plan.

 

    	 	- 10 -	 

    

    

C)  
Summary Compensation Table

 

The
following table (presented in accordance with National Instrument Form 51-102F6 - Statement of Executive Compensation ("Form
51-102F6") sets forth all annual and long term compensation for services in all capacities to the Company for the three
most recently completed financial years of the Company (to the extent required by Form 51-102F6) earned by each Named Executive
Officers (“NEO”). Form 51-102F6 defines “NEO” or “named executive officer” to mean each of
the following individuals: (a) a CEO; (b) a CFO; (c) each of the three most highly compensated executive officers of the company,
including any of its subsidiaries, or the three most highly compensated individuals acting in a similar capacity, other than the
CEO and CFO, at the end of the most recently completed financial year whose total compensation was, individually, more than $150,000
for that financial year; and (d) each individual who would be an NEO but for the fact that the individual was neither an executive
officer of the Company or its subsidiaries, nor acting in a similar capacity, at the end of that financial year.

 

	
        

        NEO Name and Principal Position
	
        Year
	
        Salary 

(US$)
	
        

        Share- Based
        Awards (1) 

(US$)
	
         

        Option-Based Awards

        (1) (2)
	Non-Equity
    Incentive Plan Compensation 

(US$) (2)	
         

         

         

         

        Pension Value 

(US$)
	
         

         

         

         

        All Other Compensation
        

(US$) (2)
	
         

         

         

        Total Compen-
        

sation 

(US$) (2)

	
         

         

        No. of Options
	
         

         

         

        (US$)
	
         

        Annual Incentive Plans
	Long- term Incentive Plans
	
        Peter Copetti (3)

        Executive Co-Chairman
	
        2015

        2014

        2013
	
        391,650

        247,963

        180,782
	
        N/A 

N/A

        N/A
	
        200,000

        600,000

        300,000
	
        188,885

        511,479

        110,996
	
        Nil 

Nil

        Nil
	
        Nil 

Nil

        Nil
	
        Nil 

Nil

        Nil
	
        Nil 

339,675

        56,495
	
        580,535

        1,099,117

        348,273

	
        Ajit Manocha (4)

        Executive Co-Chairman
	
        2015

        2014
	
        500,000

        250,000
	N/A 

N/A	
        200,000

        2,100,000
	
        188.885

        2,469,164
	Nil 

Nil	Nil 

Nil	Nil 

Nil	Nil 

Nil	
        688,885

        2,719,164

	
        Kevin Barnes (5)

        Chief Financial Officer
	
        2015

        2014

        2013
	
        84,596

        76,087

        67,793
	
        N/A 

N/A

        N/A
	
        75,000

        50,000

        200,000
	
        60,444

        42,623

        68,886
	
        Nil 

Nil

        Nil
	
        Nil 

Nil

        Nil
	
        Nil 

Nil

        Nil
	
        Nil 

Nil

        Nil
	
        145,040

        118,710

        136,679

	Stephane
    Gagnon (6) 

    Former Chief Operating Officer	
        2015

        2014

        2013
	
        84,795

        166,063

        28,247
	
        N/A 

N/A

        N/A
	
        Nil 

150,000

        800,000
	
        Nil 

127,870

        253,805
	
        Nil 

Nil

        Nil
	
        Nil 

Nil

        Nil
	
        Nil 

Nil

        Nil
	
        Nil 

7,246

        Nil
	
        84,795

        301,179

        282,052

	Daniel
    DeSimone (7) 

Former Chief Technical Officer	
        2015

        2014
	
        160,977

        114,244
	N/A 

N/A	
        540,000

        500,000
	
        348,080

        452,174
	Nil 

Nil	Nil 

Nil	Nil 

Nil	Nil 

Nil	
        509,057

        566,418

	
        Suresh Venkatesan (8)

        Chief Executive Officer
	2015	306,378	N/A	6,357,000	5,421,577	Nil	Nil	Nil	Nil	5,727,955
	
        Subhash Deshmukh (9)

        Chief Operating Officer
	2015	141,186	N/A	1,500,000	1,508,884	Nil	Nil	Nil	Nil	1,650,070

 

NOTES:

(1)   
The Company used the Black-Scholes model as the methodology to calculate the grant date fair value. The fair value will be recorded
as an operating expense as the stock options vest from the date of grant..

(2)   
The exchange rate used in these calculations to convert CAD to USD is based on the exchange rate applicable on the date of grant.

(3)   
Mr. Copetti was appointed Executive Director from June 8, 2012 to February 10, 2014. He became Interim CEO from February 11, 2014
(until June 11, 2015) and Executive Chairman on February 11, 2014. He also serves as a director of the Company, but receives no
additional compensation for services as a director. Mr. Copetti resigned as a director and as an Executive Chairman on April 30,
2016.

(4)   
Mr. Manocha was appointed to the Board on July 7, 2014 as Executive Vice-Chairman. On November 17, 2014 he was appointed a Co-Chairman
of the Board.

(5)    Mr.
Barnes served as Controller of the Company until November 30, 2012 and CFO since December 1, 2012.

(6)    Mr.
Gagnon took office on November 4 , 2013 and ceased employment with the Company on June 30, 2015.

(7)    Mr.
DeSimone ‘s role as Chief Technical Officer ended on June 8, 2015.

(8)    Dr.
Suresh Venkatesan was appointed Chief Executive Officer on June 11, 2015.

(9)    Dr. Subhash Deshmukh was
appointed Chief Operating Officer on June 8, 2015.

 

    	 	- 11 -	 

    

    

D)    
Incentive Plan Awards

 

(i)     Incentive
Plan Awards

 

The following table sets forth information concerning
all awards outstanding under the Stock Option Plan of the Company at the end of the most recently completed financial year, including
awards granted before the most recently completed financial year, to each of the Named Executive Officers:

 

	
         

         

         

         

         

         

         

        NEO Name
	Option-Based Awards	Share-Based Awards
	
        No. of Shares Underlying Unexercised Options

        (#)
	

        Option Exercise Price ($/share)
	
        Option Expiration Date
	
         

         

        Value of Unexercised In-

        The Money Options (1) 

(US$)
	
        Number of Shares or Units
        of Shares That Have Not Vested

        (#)
	
        Market or Payout Value of
        Share- Based Awards That Have Not Vested 

(US$)

	Peter Copetti	2,500,000	CA$0.235	08-June-2017	1,396,744	N/A	N/A
	500,000	CA$0.445	15-Nov-2017	203,654	N/A	N/A
	300,000	CA$0.49	13-Aug-2018	112,460	N/A	N/A
	600,000	CA$1.24	12-Aug-2019	Nil	N/A	N/A
	200,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	Ajit Manocha	2,000,000	CA$1.75	03-Jul-2019	Nil	N/A	N/A
	100,000	CA$1.24	12-Aug-2019	Nil	N/A	N/A
	200,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	Kevin Barnes	25,000	CA$0.23	16-Feb-2022	14,058	N/A	N/A
	10,000	CA$0.28	17-Mar-2020	5,263	N/A	N/A
	100,000	CA$0.44	14-Nov-2018	41,091	N/A	N/A
	100,000	CA$0.445	15-Nov-2017	40,731	N/A	N/A
	100,000	CA$0.49	13-Aug-2018	37,488	N/A	N/A
	25,000	CA$0.51	28-Sep-2021	9,011	N/A	N/A
	50,000	CA$0.76	28-Feb-2021	9,011	N/A	N/A
	50,000	CA$1.24	12-Aug-2019	Nil	N/A	N/A
	50,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	25,000	CA$1.08	13-Aug-2020	Nil	N/A	N/A
	Stephane Gagnon	300,000	CA$0.43	4-Oct-2018	25,422	N/A	N/A
	500,000	CA$0.44	14-Nov-2018	37,663	N/A	N/A
	150,000	CA$1.24	12-Aug-2019	29,891	N/A	N/A
	Daniel DeSimone	200,000	CA$1.44	03-Apr-2019	Nil	N/A	N/A
	300,000	CA$1.24	12-Aug-2019	Nil	N/A	N.A
	40,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	500,000	CA$1.65	30-Mar-2020	Nil	N/A	N/A
	Dr. Suresh Venkatesan	
         

        6,357,000
	
         

        CA$1.40
	
         

        15-Jun-2020
	
         

        Nil
	
         

        N/A
	
         

        N/A

	Dr. Subhash Deshmukh	
         

        1,500,000
	
         

        CA$1.62
	
         

        24-Apr-2020
	
         

        Nil
	
         

        N/A
	
         

        N/A

 

1)
 This amount is calculated based on the difference between the market value of the shares underlying the vested and unvested
options at the end of the most recently completed financial year, being CA$1.01 (US$0.7209), and the exercise or base price of
the option. The exchange rate used in these calculations to convert CAD to USD was 0.7209, being the rate on December 31, 2015

 

    	 	- 12 -	 

    

    

(ii)    Outstanding Share-Based
Awards and option-Based Awards – Value Vested or Earned During the Year

 

The
value vested or earned during the most recently completed financial year of incentive plan awards granted to Named Executive Officers
are as follows:

 

	
         

         

         

        NEO Name
	
        Option-Based Awards - Value Vested

        During The Year (1)

        (US$)
	
        Share-Based Awards - Value Vested

        During The Year (2)

        (US$)
	
        Non-Equity Incentive Plan
        Compensation - Value Earned During The Year

        (US$)

	Peter Copetti	60,540	N/A	Nil
	Ajit Manocha	2,187	N/A	Nil
	Kevin Barnes	38,850	N/A	Nil
	Stephane Gagnon	47,181	N/A	Nil
	Daniel DeSimone	18,885	N/A	Nil
	Dr. Suresh Venkatesan	Nil	N/A	Nil
	Dr. Subhash Deshmukh	Nil	N/A	Nil

 

(1)  
This amount is the dollar value that would have been realized computed by obtaining the difference between the market price of
the underlying securities on the vesting date and the exercise or base price of the options under the option-based award. For
the NEOs to have realized this value, they would have had to exercise their options and sell the shares on the day of vesting.
The exchange rate used in these calculations to convert CAD to USD was 0.7209, being the rate on December 31, 2015.

(2)  
This amount is the dollar value realized computed by multiplying the number of shares or units by the market value of the underlying
shares on the vesting date.

 

(iii)    Narrative
Discussion

 

The current stock option plan of the Company is
the 2015 Fixed Stock Option Plan (the "2015 Plan") which was approved by the disinterested shareholders of the Company
on June 12, 2015 and accepted for filing by the TSXV). Under the 2015 Plan, the Company is required to reserve a number of shares
eligible for granting under the Plan, which needs to be approved by shareholders and cannot exceed 20% of the issued and outstanding
shares. The 2015 Plan reserved 36,326,000 shares as the maximum number (the "Fixed Number") of common shares which may
be issued pursuant to options granted under the 2015 Plan and previous plans.

 

On November 10, 2015, the directors resolved to increase
the Fixed Number of shares reserved for issuance under the Company’s Stock Option Plan to such number equal to 20% of the
issued and outstanding shares of the Company on the day prior to the Meeting, subject to shareholder and TSXV approval. For more
information refer to the section entitled “Approval of Stock Option Plan”.

 

The purpose of the Plan is to allow the Company to
grant options to directors, officers, employees and consultants, as additional compensation, and as an opportunity to participate
in the success of the Company. The granting of such options is intended to align the interests of such persons with that of the
shareholders. Options are exercisable over periods of up to ten (10) years as determined by the Board and are required to have
an exercise price no less than the closing market price of the Company’s shares prevailing on the last trading day before
the option is granted less a discount of up to 25%, the amount of the discount varying with market price in accordance with the
policies of the TSXV. Generally, the Company does not grant options at a discount to the market price. Pursuant to the Plan, the
Board may from time to time authorize the issue of options to directors, officers, employees and consultants of the Company and
its subsidiaries or employees of companies providing management or consulting services to the Company or its subsidiaries. In addition,
as a percentage of the issued and outstanding shares at the time of grant, the number of shares which may be reserved for issuance:

 

(a)    
to all optionees under the Stock Option Plan in aggregate shall not exceed 20%;

(b)    
to all insiders as a group may not exceed 20%; and

    	 	- 13 -	 

    

    

 

(c)    
to any one individual may not exceed 2% on a yearly basis if the optionee is engaged in investor relations activities or
is a consultant.

 

Previously, options granted under the Plan generally
vested as to 25% six months from the day of grant and 25% every six months thereafter. By resolution of the Directors dated February
25, 2016, it was resolved that, generally, the terms of stock options would be ten years with 25% of the stock options vesting
on the first anniversary of the grant of the options and the balance vesting quarterly for three years thereafter. However, the
Board can vary the vesting schedule for differing purposes, subject to complying with TSXV Policies.

 

The Plan provides that if a change of control, as defined
therein, occurs, all shares subject to option shall immediately become vested and may thereupon be exercised in whole or in part
by the option holder. The exercise price for options is generally set at the closing price of the common shares of the Company
as of the last trading day prior to the date of the grant of the options, in accordance with TSXV Policies.

 

As at December 31, 2015, the number of outstanding
options granted under the Stock Option Plan was 26,718,500. For more information, refer to Note 9 “Stock Option and Contributed
Surplus” in the Company’s audited financial statements for the year ended December 31, 2015. The criteria for determining
awards to the NEOs is described under the “Stock Options” subsection of “Description and Explanation
of Elements of Compensation”. As of May 24, 2016, the number of outstanding options granted under the Stock Option Plan
was 25,680,500.

 

The Company’s Non-Equity Incentive Plan for
compensation to the NEOs along with the criteria for determining awards is described under the “Variable Pay Compensation”
subsection of “Description and Explanation of Elements of Compensation”.

 

E)    
Pension Plan Benefits

 

(i)       
Defined Benefit Plans

    The Company does not provide a defined benefit plan to
the NEOs or any of its employees.

(ii)       
Defined Contribution Plans

    The Company offers a defined contribution plan that
is a 401K Plan for the US Subsidiary but does not contribute toward such plan.

(iii)     
Deferred Compensation Plans

    The Company does not have any Deferred Compensation
Plans other than that described above.

 

F)    
Termination and Change of Control Benefits

 

The Company and/or its subsidiaries have employment
contracts with the following Named Executive Officer as follows:

 

•      Mr.
Copetti entered into an Employment Agreement with the Company, dated February 10, 2014 (the “Agreement”), wherein
(i) he was paid CA$20,000 per month or (CA$240,000 per year) until December 31, 2014, (ii) he is eligible for annual
and special bonuses as determined by the Board of Directors; (iii) he is reimbursed up to CA$5,000 for gym membership and
medical tests; and (iv)   he will receive a severance of twelve months on
termination of employment by the Company, other than for cause. Mr. Copetti’s salary was adjusted to CA$31,250 per
month or (CA$375,000 per year) in October 2014. Mr. Copetti’s employment agreement was extended on a month to month
basis with an adjusted salary of CA$41,667.67 per month. On October 1, 2015, the Company extended Mr. Copetti’s
employment agreement. The extended agreement divided his compensation between his compensation as an executive and his
compensation as the Co- Chariman of the Board. As of October 1, 2015, Mr. Copetti is paid, annually, CA$375,000 as an
executive and US$125,000 as Co-Chairman of the Board. The other terms of the contract remained unchanged.

 

    	 	- 14 -	 

    

    

•      Mr.
Manocha entered into a memorandum of understanding (MOU) dated July 3, 2014, wherein (i) he will be paid US$41,667.67 per
month (or US$500,000 per year) and he was granted 2,000,000 stock options. Mr. Manocha’s MOU was accepted. On
October 1, 2015, the Company extended Mr. Manocha’s employment at the same annual rate of pay. The extension, however,
divided his compensation between his compensation as an executive and his compensation as the Co-Chairman of the Board. As of
October 1, 2015, Mr. Manocha is paid annually US$375,000 as an executive and US$125,000 as Co-Chairman of the Board.

 

•      Mr. DeSimone entered into Letter of Agreement dated March 28, 2014, wherein (i) he will be paid US$10,416.67 per
month (or US$125,000 per year) and (ii) he was granted 200,000 stock options exerciseable for a period expiring on April 3, 2019
at a price of $1.44 per share.

 

•      Dr. Venkatesan entered into an Executive Employment Agreement with an effective date of June 10, 2015 wherein (i)
he will be paid US$550,000 per year under at-will terms of employment; (ii) he will be eligible for annual and special bonuses
as determined by the Board of Directors; (iii) he was granted 6,357,000 stock options vesting over 4 years; (iv) he is eligible
for a signing bonus of US$450,000 payable on the first anniversary of the effective date provided that the Executive Employment
Agreement has not been terminated prior to that date; (v) he will receive a severance of twelve months on termination of employment
by the Company, other than for cause.

 

•      Dr. Deshmukh entered into an Executive Employment Agreement with an effective date of June 8, 2015 wherein (i) he
will be paid US$250,000 (subsequently amended to US$300,000 effective January 1, 2016) per year under at-will terms of employment;
(ii) he will be eligible for annual and special bonuses as determined by the Board of Directors; (iii) he was granted 1,500,000
stock options vesting over 4 years; (iv) he will receive a severance of six months’ salary, if terminated during the first
year of employment, plus two months’ salary additional per each full year of employment thereafter, up to a maximum of twelve
months of termination of employment by the Company, other than for cause.

 

G)  
Compensation of Directors

 

(i)   Director Compensation Table

 

The following table sets forth all amounts of compensation provided to
the directors, who are each not also a Named Executive Officer, for the Company’s most recently completed financial year:

 

	
         

         

        Director 

Name (1)
	
        Fees or Salary (2)
        

(US$)
	Share- Based Awards 

(US$)	Option-Based
    Awards (2)(3)	Non-Equity Incentive Plan Compensation 

(US$)	
         Pension Value 

(US$)
	
        All Other Compensation
        

(US$)
	
        Total 

(US$)

	No. of 

Options	Value 

(US$)
	Adam
    Chowaniec (5)	1,205	N/A	Nil	Nil	N/A	N/A	N/A	1,205
	Sheldon
    Inwentash (6)	19,533	N/A	100,000	Nil	N/A	N/A	N/A	19,533
	John
    F. O’Donnell (4)	60,118	N/A	100,000	94,442	N/A	N/A	N/A	154,560
	Todd
    A. DeBonis (7)	39,135	N/A	525,000	561,789	N/A	N/A	N/A	600,924
	David
    E. Lazovsky (7)	30,135	N/A	275,000	325,683	N/A	N/A	N/A	355,818
	Chris Tsiofas	66,385	N/A	300,000	283,328	N/A	N/A	N/A	349,713
	Mohandas
    Warrior (8)	22,170	N/A	250,000	122,808	N/A	N/A	N/A	144,978
	Dr.
    Geoff Taylor (9)	nil	N/A	100,000	94,442	N/A	N/A	N/A	94,442

 

(1)    
Relevant disclosure has been provided in the Summary Compensation Table above, for directors who are also Named Executive
Officers.

(2)    
The exchange rate used in these calculations to convert CAD to USD is based on the exchange rate applicable on the date of grant.

    	 	- 15 -	 

    

    

 

(3)    
The Company used the Black-Scholes model as the methodology to calculate the grant date fair value. The fair value will be recorded
as an operating expense as the stock options vest from the date of grant.

(4)    
The firm of Stikeman Keeley Spiegel Pasternack LLP of which Mr. O’Donnell is counsel was paid the sum of USD

$107,790 for legal fees and disbursements incurred
in 2015.

(5)    
Dr. Chowaniec resigned from the Board on January 22, 2015.

(6)    
Mr. Inwentash resigned from the Board on August 13, 2015 at which time all 100,000 stock options above were cancelled. No value
was assigned to the stock options. 125,000 stock options from a previous stock option grant were also cancelled.

(7)    
Messrs. DeBonis and Lazovsky were appointed to the Board on April 8, 2015.

(8)    
Mr. Warrior was appointed to the Board on June 15, 2015.

(9)    
Dr. Taylor resigned as a director on August 12, 2015 but continued to serve as the Company’s Chief Scientist until his resignation
which is effective April 30, 2016. Dr. Taylor did not receive fees as a director but received US$ 205,228 in consulting fees for
acting as Chief Scientist for the Company.

 

(ii)    Narrative
Discussion

 

During the year ended December 31, 2015, the outside,
or non-management, directors, other than the Named Executive Officers, were paid an annual fee of $32,000 for acting as a director,
plus $1,500 per board meeting attended and $750 per committee meeting, to be paid quarterly. At the beginning of the year the fees
were denominated in CDN dollars but effective for the quarter ended September 30, 2015, the fees were denominated in US dollars.
If independent, the Chairman of the Board is entitled to receive an additional $10,000 annually and the Committee Chairs are entitled
to receive an additional $8,000 annually. Messrs. Copetti and Manocha both served as Executive Co-Chairman in 2015. Mr. Copetti
also served as Interim CEO until June 11, 2015. The directors were also entitled to be reimbursed for their actual out of pocket
expenses incurred in carrying out their duties. Director’s involvement in special assignments or services as consultant or
expert will be negotiated on a case by case basis.

 

The directors participate in the Company’s
Stock Option Plan for the granting of incentive stock options to the officers, employees and directors, which Plan is described
under the subsection “Narrative Discussion” of “Incentive Plan Awards” and under “Approval
of Stock Option Plan”. The purpose of granting such options is to assist the Company in compensating, attracting, retaining
and motivating the directors of the Company and to closely align the personal interests of such persons to that of the shareholders.

 

(iii)   Incentive
Plan Awards - Outstanding Share-Based Awards and Option-Based Awards

 

The
following table sets forth information as at December 31st, 2015, the end of the most recently completed financial year, concerning
all awards outstanding under incentive plans of the Company, including awards granted before the most recently completed financial
year, to each of the directors who are not Named Executive Officers:

 

	 	Option-Based Awards	Share-Based Awards
	
         

         

         

         

         

        Director Name
	
        Number of Securities Underlying
        Unexercised Options

        (#)
	
        Option Exercise Price

        ($)
	
        Option Expiration Date
	
        Value of Unexercised
        In-The-Money Options (1)(2) 

        (US$)
	
        Number of Shares or Units
        of Shares That Have Not Vested

        (#)
	
        Market or Payout Value of Share- Based Awards
        That Have Not Vested

        (US$)

	John F. O’Donnell	150,000	CA$0.23	16-Feb-2022	84,345	N/A	N/A
	12,500	CA$0.345	19-Aug-2020	5,992	N/A	N/A
	500,000	CA$0.445	15-Nov-2017	203,654	N/A	N/A
	300,000	CA$0.49	13-Aug-2018	112,460	N/A	N/A
	300,000	CA$1.24	12-Aug-2019	Nil	N/A	N/A

 

    	 	- 16 -	 

    

    

 

	 	Option-Based Awards	Share-Based Awards
	
        Director Name
	
        Number of Securities Underlying
        Unexercised Options

        (#)
	
        Option Exercise Price

        ($)
	
        Option Expiration Date
	
         

        Value of Unexercised In-The-Money
        Options (1)(2) 

        (US$)
	
        Number of Shares or Units
        of Shares That Have Not Vested

        (#)
	
        Market or Payout Value of Share- Based Awards
        That Have Not Vested

        (US$)

	 	100,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	Chris Tsiofas	500,000	CA$0.275	21-Aug-2017	264,931	N/A	N/A
	500,000	CA$0.445	15-Nov-2017	203,654	N/A	N/A
	300,000	CA$0.49	13-Aug-2018	112,460	N/A	N/A
	300,000	CA$1.24	12-Aug-2019	Nil	N/A	N/A
	300,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	Todd A. DeBonis	275,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	250,000	CA$1.99	08-Apr-2020	Nil	N/A	N/A
	David E. Lazovsky	250,000	CA$1.99	08-Apr-2020	Nil	N/A	N/A
	25,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	Mohandas Warrior	250,000	CA$1.54	12-Jun-2020	Nil	N/A	N/A
	Geoff
    Taylor (3)	75,000	CA$ 0.23	16-Feb-2022	79,403	N/A	N/A
	30,000	CA$ 0.28	17-Mar-2020	30,470	N/A	N/A
	10,000	CA$ 0.345	19-Aug-2020	9,597	N/A	N/A
	1,500,000	CA$ 0.445	15-Nov-2017	1,310,466	N/A	N/A
	300,000	CA$ 0.49	13-Aug-2018	250,473	N/A	N/A
	100,000	CA$ 0.51	28-Sep-2021	81,770	N/A	N/A
	500,000	CA$ 0.51	2-Apr-2018	408,848	N/A	N/A
	75,000	CA$ 0.76	28-Feb-2021	45,188	N/A	N/A
	300,000	CA$1.24	12-Aug-2019	56,808	N/A	N/A

 

(1)  
This amount is calculated based on the difference between the market value of the securities underlying the options at the end
of the most recently completed financial year, which was CA$1.01 (US$0.7209), and the exercise or base price of the option.

 

(2)  
The exchange rate used in these calculations to convert CAD to USD was 0.7209, being the rate on December 31, 2015.

 

(3)  
Geoff Taylor resigned as a director of the Company on August 12, 2015.

 

(iv)      Incentive Plan
Awards - Value Vested or Earned During the Year

 

The
value vested or earned during the most recently completed financial year of incentive plan awards granted to directors who are
not Named Executive Officers are as follows:

 

	
         

         

         

         

        Director Name
	
         

        Option-Based Awards

        - Value Vested
        During The Year (1)

 (US$)
	
         

        Share-Based Awards - Value Vested

        During The Year 

(US$)
	
        Non-Equity Incentive Plan
        Compensation - Value Earned

        During The Year 

(US$)

	Sheldon Inwentash	10,935	N/A	N/A

 

    	 	- 17 -	 

    

    

 

	
         

         

         

         

        Director Name
	
         

        Option-Based Awards

        - Value Vested
        During The Year (1) 

        (US$)
	
         

        Share-Based Awards - Value Vested

        During The Year 

(US$)
	
        Non-Equity Incentive Plan
        Compensation - Value Earned

        During The Year 

(US$)

	John F. O’Donnell	53,979	N/A	N/A
	Chris Tsiofas	53,979	N/A	N/A
	Geoff Taylor	64,914	N/A	N/A

 

(1) 
 This amount is the dollar value that would have been realized computed by obtaining the difference between the market price of
the underlying securities on the vesting date and the exercise or base price of the options under the option-based award. For
the directors to have realized this value, they would have had to exercise their options and sell the shares on the day of vesting.
None of these options were exercised.

 

(2) 
The exchange rate used in these calculations to convert CAD to USD was the exchange rate applicable on the vesting date.

 

H)   
Securities Authorized for Issuance Under Equity Compensation Plans

 

The
following table sets forth the Company's compensation plans under which equity securities are authorized for issuance as at December
31, 2015, being the end of the most recently completed financial year.

 

	
         

         

         

         

        Plan Category
	Number of securities to be issued upon exercise of outstanding options, warrants and rights	
         

        Weighted-average exercise price of
        outstanding options, warrants and rights
	
         

        Number of securities remaining
        available for future issuance under equity compensation

	
        Equity compensation plans approved by securityholders

        2015 Stock Option Plan
	
        26,718,500
	
        0.89
	
        2,072,500

 

INDEBTEDNESS TO COMPANY OF DIRECTORS,
EXECUTIVE OFFICERS AND SENIOR OFFICERS

 

As at the date hereof, there is no indebtedness of
any current or former director, executive officer or employee of the Company or any subsidiaries which is owing to the Company
or any of its subsidiaries or to another entity which is the subject of a guarantee, support agreement, letter of credit or other
similar arrangement or understanding provided by the Company or any of its subsidiaries, entered into in connection with a purchase
of securities or otherwise.

 

No individual who is, or at any time during the most
recently completed financial year was, a director or executive officer of the Company, no proposed nominee for election as a director
of the Company and no associate of such persons:

 

(i)     is or at any time since the beginning of the most recently completed financial year has been, indebted to the Company or
any of its subsidiaries; or

(ii)  
whose indebtedness to another entity is, or at any time since the beginning of the most recently completed financial year
has been, the subject of a guarantee, support agreement, letter of credit or other similar arrangement or understanding provided
by the Company or any of its subsidiaries in relation to a securities purchase program or other program.

 

INTEREST OF CERTAIN PERSONS IN MATTERS
TO BE ACTED UPON

 

Except as set out herein, no person who has been a
director or executive officer of the Company at any time since the beginning of the Company's last financial year, no proposed
nominee of Management of the Company for election as a director of the Company and no associate or affiliate of the foregoing persons,
has any material interest, direct or indirect, by way of beneficial ownership or otherwise, in

 

    	 	- 18 -	 

    

    

matters to be acted upon at the Meeting other than the
election of directors and potentially, the amendment of the Company’s stock Option Plan.

 

INTEREST OF INFORMED PERSONS IN MATERIAL
TRANSACTIONS

 

No informed person or proposed director of the Company
and no associate or affiliate of the foregoing persons has or has had any material interest, direct or indirect, in any transaction
since the commencement of the Company's most recently completed financial year or in any proposed transaction which in either such
case has materially affected or would materially affect the Company or any of its subsidiaries, except for stock option grants.

 

APPOINTMENT OF AUDITORS

 

Marcum LLP, Certified Public Accountants, of New Haven,
Connecticut, are the auditors of the Company.

 

At the Meeting, shareholders will be asked to appoint
Marcum LLP as the auditors of the Company to hold office for the ensuing year at a remuneration to be fixed by the directors.

 

Unless otherwise instructed, the
proxies given pursuant to this solicitation will be voted for the re- appointment of Marcum LLP as the auditors of the Company
to hold office for the ensuing year at a remuneration to be fixed by the directors.

 

MANAGEMENT CONTRACTS

 

No management functions of the Company or its subsidiaries
are performed to any substantial degree by a person other than the directors or executive officers of the Company or its subsidiaries.

 

CORPORATE GOVERNANCE DISCLOSURE

 

A summary of the responsibilities and activities and
the membership of each of the Committees is set out below.

 

National Instrument (“NI”) 58-201 establishes
corporate governance guidelines which apply to all public companies. The Company has reviewed its own corporate governance practices
in light of these guidelines. In certain cases, the Company’s practices comply with the guidelines, however, the Board considers
that some of the guidelines are not suitable for the Company at its current stage of development and therefore these guidelines
have not been adopted. NI 58-101 mandates disclosure of corporate governance practices which disclosure is set out below.

 

Independence of Members
of Board

 

Since the resignation of Peter Copetti on August 30,
2016, the Company's current Board consists of 7 directors, four (4) of whom are independent based upon the tests for independence
set forth in NI 52-110. Todd DeBonis, David Lazovsky, Mohandas Warrior and Chris Tsiofas are the independent directors. Ajit Manocha
is not independent as he is the Executive Chairman of the Company. John O’Donnell is not independent as he acts as legal
counsel to the Company. Dr. Suresh Venkatesan is not independent as he is the Chief Executive Officer of the Company.

 

Management Supervision
by Board

 

During most of 2015, independent supervision of Management
was accomplished through its independent Board members, notwithstanding that the Co-Chairmen of the Board were not independent.
In 2015, three new independent directors were appointed to the Board to fill Board vacancies. The Board considered that Management
was effectively supervised by the independent directors as the independent directors were actively and regularly involved in reviewing
and supervising the operations of the Company and had regular and full access to Management. The CEO and CFO reported upon the
operations of the Company separately to the independent directors of the Board at such other times throughout the year as was considered
necessary or advisable by the independent directors. The independent directors were encouraged to meet at any time they consider
necessary without any members of Management including the non-independent directors being present, and generally did so several
times per year by adjourning

 

    	 	- 19 -	 

    

    

Board meetings and asking all persons who were not
independent directors to leave the room. The Company's auditors, legal counsel and employees may have been invited to attend. Further
supervision was performed through the Audit Committee currently composed of all independent directors, who meet with the Company's
auditors without Management being in attendance, generally on a quarterly basis and at least once a year. Additional supervision
was performed through the Compensation Committee and the Corporate Governance and Nominating Committee (the “CGNC”),
both of which were composed of a majority of independent directors. The CGNC has determined that the current constitution of the
Board of seven (7) directors is appropriate for the Company's current stage of development. The Board currently has a majority
of independent directors.

 

Participation of
Directors in Other Reporting Issuers

 

No director of the Company, nor any proposed nominee
for election as a director, hold directorships in other reporting issuers, except for John F. O’Donnell who is a director
and Chairman of the Board of Montana Gold Mining Company (CSE: MGM) and Todd DeBonis who is a director and President and CEO of
Pixelworks, Inc. (NASDAQ: PXLW).

 

Orientation and Continuing
Education

 

While the Company does not have formal orientation and
training programs, new Board members are provided with:

 

1.    
information respecting the functioning of the Board, committees and copies of the Company's corporate governance policies;

 

2.    
access to recent, publicly filed documents of the Company, technical reports and the Company's internal financial information;

 

3.    
access to Management and technical experts and consultants; and

 

4.    
advice to consult on the internet the TSXV Policy relating to Corporate Governance and applicable regulations and policies
and also the applicable securities laws, rules and regulations.

 

Board members are encouraged to communicate with Management,
auditors and technical consultants; to keep themselves current with industry trends and developments and changes in legislation
with Management’s assistance; and to attend related industry seminars and visit the Company’s operations. Board members
have full access to the Company's records.

 

Ethical Business
Conduct

 

The Board views good corporate governance as an integral
component to the success of the Company and to meet responsibilities to shareholders. The Board has adopted a Code of Conduct which
was updated on February 25, 2016 and has instructed its Management and employees to abide by the provisions of the Code. A copy
of said code is posted on the Company’s website <www.poet- technologies.com>.

The directors of the Corporation are responsible for
monitoring compliance with this Code, for regularly assessing its adequacy, for interpreting this Code in any particular situation
and for approving any changes to this Code from time to time.

 

Investor Relations
Disclosure Policy

 

The Board has established a Company Disclosure Policy
related to disclosure and external communications, which applies to all officers, directors and employees of the Company. The purpose
of the Policy is to ensure compliance with legal and regulatory requirements, when preparing public disclosure documents, answering
investor inquiries and/or attending conferences or meetings with its analysts and institutional shareholders. This policy covers
disclosures in documents filed with the securities regulators and written statements made in POET's annual and quarterly reports,
news releases, letters to shareholders, presentations (both of a business or technical nature), marketing materials, advertisements,
and information contained on POET's website and other electronic communications. It also extends to oral statements made in meetings
and telephone conversations with

    	 	- 20 -	 

    

    

 

analysts and investors, interviews with the media as
well as speeches, press conferences, and conference calls.

 

Trading by Insiders

 

Insiders of the Company are expected to comply with
all applicable Regulatory Laws, Rules and Regulations with respect to buying and selling shares of the Company. In addition, the
Company has well-defined criteria for when the Trading Window for officers and directors opens and closes as per the Company’s
Securities Trading Policy posted on its website <www.poet-technologies.com>, the purpose of which is to ensure that Insiders
do not trade shares of the Company at inappropriate times. Insiders are expected to abstain from trading the shares of the Company
when the Trading Window is closed.

 

Nomination of Directors

 

The Board established a Corporate Governance and Nominating
Committee (the “CGNC”) currently composed of John O’Donnell (Chairman of the CGNC), Ajit Manocha and Chris Tsiofas.
The CGNC has the responsibility for identifying potential Board candidates. The CGNC assesses potential Board candidates to fill
perceived needs on the Board for required skills, expertise, independence and other factors. Members of the Board and representatives
of the semi-conductor and infrared industries are consulted for possible candidates. The Board has adopted a written charter that
sets forth the responsibilities of the CGNC. In addition to its Board identification responsibilities, the CGNC is mandated to
take a leadership role in shaping corporate governance by overseeing and assessing the functioning of the Board and the committees
of the Board and developing, implementing and assessing effective corporate governance processes and practices. The Charter was
recently amended and a copy is posted on the Company’s website <www.poet-technologies.com>.

 

Compensation of Directors
and the CEO

 

On December 14, 2007, the Company established a Compensation
Committee (the “CC”) to be responsible for reviewing all overall compensation strategy, objectives and policies; annually
reviewing and assessing the performance of the executive officers; recommending to the Board the compensation of the executive
officers; reviewing executive appointments; and recommending the adequacy and form of directors' compensation. The CC also reviews
and recommends incentive stock option awards under the Company’s Stock Option Plan. The current members of the CC are Chris
Tsiofas (Chairman of the CC), Todd DeBonis, Ajit Manocha and John O’Donnell. Mr. Manocha joined the CC on February 25, 2016.

 

The CC discusses and makes recommendations to the Board
for approval or disapproval of all compensation issues that pertain to the Company. The compensation programs of the Company are
designed to reward performance and to be competitive with the compensation agreements of other comparable semiconductor companies.
The CC is responsible for evaluating the compensation of the senior Management and assuring that they are compensated effectively
in a manner consistent with the Company’s business, stage of development, financial condition and prospects, and the competitive
environment. Specifically, the CC is responsible for: (i) reviewing the compensation practices and policies of the Company to ensure
that they are competitive and that they provide appropriate motivation for corporate performance and increased shareholder value;
(ii) overseeing the administration of the Company’s compensation programs, and reviewing and approving the employees who
receive compensation and the nature of the compensation provided under such programs, and ensuring that all Management compensation
programs are linked to meaningful and measurable performance targets; (iii) making recommendations to the Board regarding the adoption,
amendment or termination of compensation programs and the approval of the adoption, amendment and termination of compensation programs
of the Company, including for greater certainty, ensuring that if any equity-based compensation plan is subject to shareholder
approval, and that such approval is sought; (iv) periodically surveying the executive compensation practices of other comparable
companies; (v) establishing and ensuring the satisfaction of performance goals for performance-based compensation; (vi) annually
reviewing and approving the annual base salary and bonus targets for the senior executives of the Company, other than the CEO;
(vii) reviewing and approving annual corporate goals and objectives for the CEO and evaluating the CEO’s performance against
such goals and objectives; (viii) annually reviewing and approving, based

 

    	 	- 21 -	 

    

    

on the CC’s evaluation of the CEO, the CEO’s
annual base salary, the CEO’s bonus, and any stock option grants and other awards to the CEO under the Company’s compensation
programs (in determining the CEO’s compensation, the CC will consider the Company’s performance and relative shareholder
return, the compensation of CEOs at other companies, and the CEO’s compensation in past years); and

 

(ix) review the annual report on executive compensation
required to be prepared under applicable corporate and securities legislation and regulation including the disclosure concerning
members of the CC and settling the reports required to be made by the CC in any document required to be filed with a regulatory
authority and/or distributed to shareholders.

 

The Compensation Committee has engaged Compensia to
conduct a Peer Group review that was prepared with the input of the CEO. A draft Peer Group was circulated and the CEO felt it
was appropriate. Compensia has given guidance to the Compensation Committee with respect to appropriate comparative terms for its
incentive stock option plan and a comparative salary review of various positions relative to the Peer Group. The Compensation Committee
will utilize the comparative reviews to assist in making appropriate recommendations.

 

Board Committees

 

In addition to its responsibility for nominating directors,
the CGNC also has the responsibility for monitoring corporate governance compliance and setting corporate governance policy.

 

The Company also has a Disclosure Committee who meet
periodically, as needed, to review the Company’s material news disclosure prior to dissemination. The current members of
the Disclosure Committee are Suresh Venkatesan, John O’Donnell and Chris Tsiofas by reason of their positions as CEO, Chairman
of the CGNC and Chairman of the Audit Committee respectively. On February 25, 2016, the Directors, on the advice of the CGNC resolved
that the CGNC be authorized as it may determine, on a case by case basis, to add a supplemental member to the Committee as a subject
matter expert, depending on the nature of the disclosure, to ensure the appropriateness of the disclosure.

 

As the directors are actively involved in the operations
of the Company, the Board has determined that additional committees, other than the AC, the CGNC and the CC, are not necessary
at this stage of the Company’s development.

 

Assessments

 

The Board annually, at such times as it deemed appropriate,
reviewed the performance and effectiveness of the Board, the directors and its committees to determine whether changes in size,
personnel or responsibilities are warranted. To assist in its review, the Board conducted informal surveys of its directors, received
reports from the CGNC on its assessment of the functioning of the Board and reports from each committee respecting its own effectiveness.

 

Audit Committee

 

A)   THE AUDIT COMMITTEE'S
CHARTER

 

The current Audit Committee Charter was put in place on December 14, 2007,
a copy of which can be found in Appendix “A” and has been reviewed periodically since that time.

 

B)   COMPOSITION OF THE AUDIT COMMITTEE

 

The following are the current members of the Committee:

 

	 	 	Independent /	 	Financially literate / Not
	Name	 	Not independent (1)	 	Financially literate (1)
	Chris Tsiofas	 	Independent	 	Financially literate
	David E. Lazovsky	 	Independent	 	Financially literate
	Mohandas Warrior	 	Independent	 	Financially literate
	 	 	 	 	 
	(1)   As defined by National Instrument 52-110
    ("NI 52-110").

 

    	 	- 22 -	 

    

    

C)   RELEVANT EDUCATION AND EXPERIENCE

 

The education and experience of each Audit Committee
member that is relevant to the performance of his responsibilities are as follows:

 

Chris Tsiofas, the Chairman of the Audit Committee,
holds B. Comm. from the University of Toronto. He has been a member of the Institute of Chartered Accountants of Ontario since
1993 and also a member of the Canadian Tax Foundation. He is a Partner with Myers Tsiofas Norheim LLP.

 

David E. Lazovsky holds a B.S. in mechanical engineering
from Ohio University. He is the founder of Intermolecular and served as the company’s President and Chief Executive Officer
and as a member of the board of directors from September 2004 to October 2014. Prior to founding Intermolecular, Mr. Lazovsky held
several senior management positions at Applied Materials.

 

Mohandas Warrior has been the President & CEO
of Alfalight, Inc. since 2004 – a high power diode laser company which serves military and industrial customers. Mohan is
a 30+ year semiconductor industry veteran with 15 years of experience at Motorola Semiconductors where he held senior executive
responsibilities in engineering and operations. Following Motorola, he successfully launched two venture-backed companies in Austin,
Texas. He was a founding charter member of the Austin chapter of TiE and served on the Texas Higher Education Panel. He has also
served on the Electronics Materials panel of the National Science Foundation and has been an invited speaker/panelist to many semiconductor
forums. He serves on the Boards of several opto-electronic and technology companies. Mohan’s academic credentials include
a BS in Chemical Engineering from IIT Delhi, a MS in Chemical Engineering from Syracuse University and an MBA from the Kellogg
School of Management at Northwestern University.

 

All members have an understanding of the accounting
principles used by the Company to prepare its financial statements and have an understanding of its internal controls and procedures
for financial reporting.

 

D)   AUDIT COMMITTEE OVERSIGHT

 

At no time since the commencement of the Company's
most recently completed financial year was a recommendation of the Committee to nominate or compensate an external auditor not
adopted by the Board of Directors.

 

E)   RELIANCE ON CERTAIN EXEMPTIONS

 

At no time since the commencement of the Company's
most recently completed financial year has the Company relied on the exemption in Section 2.4 of NI 52-110 (De Minimis Non-audit
Services), or an exemption from NI 52-110, in whole or in part, granted under Part 8 of NI 52-110.

 

F)  PRE-APPROVAL POLICIES AND PROCEDURES

 

The Committee has adopted specific policies and
procedures for the engagement of non-audit services as described above in paragraph 7 (e) of the Audit Committee Charter.

 

G)   EXTERNAL AUDITORS SERVICE FEES (BY
CATEGORY)

 

The aggregate fees billed by the Company's external
auditors for each of the last two fiscal years for audit fees are as follows:

 

	Financial Year Ending	Audit Fees	Audit Related Fees	Tax Fees	All Other Fees
	December
    31, 2014 (1)	$59,000	nil	nil	$10,000
	December
    31, 2015 (1)	$69,000	nil	nil	$ 8,850

 

(1)     
The fees include those for the subsidiaries of the Company, since the audits were completed by the same firm.

 

    	 	- 23 -	 

    

    

Expectations of Management

 

The Board expects Management to operate the business
of the Company in a manner that enhances shareholder value and is consistent with the highest level of integrity. Management is
expected to execute the Company's business plan and to meet performance goals and objectives.

 

PARTICULARS OF OTHER MATTERS TO BE ACTED
UPON

 

The Company is seeking shareholders’ approval
for: (a) amendments to the Company’s Stock Option Plan.

 

A)    
Approval of Stock Option Plan

 

Introduction

 

On June 12, 2015, Shareholders of the Company approved
the 2015 Plan whereby the number of Shares (the “Fixed Number”) issuable under the Plan had been increased to 36,326,000,
representing 20% of the issued and outstanding shares of the Company at the time approved by the directors.

The full text of the 2015 Plan is available from the
Company’s website and also from SEDAR website as “Other Securityholder Document”.

 

On November 10, 2015, the directors resolved to increase
the Fixed Number of shares reserved for issuance under the Company’s Stock Option Plan to such number equal to 20% of the
issued and outstanding shares of the Company on the day prior to the Meeting, subject to shareholder and TSXV approval. (the “2016
Plan”). All other terms and conditions remain unchanged. As at May 24, 2016 were 217,758,337 Shares of the Company issued
and outstanding. If that amount remains unchanged between now and the day before the Meeting, the Fixed Number issuable under the
Plan will be increased to 43,551,667, an increase of 7,225,667 Shares reserved for issuance under the Plan.

 

To be effective, the Company must obtain approval of
a simple majority of the shareholders at the Meeting, to the increase in the number of options, but excluding insiders and their
associates, (the "disinterested shareholders") with respect to the adoption of the 2016 Plan. For the purposes hereof,
an "Insider" is a director or senior of the Company, a director or senior officer of a company that is itself an Insider
or subsidiary of the Company, or a person whose control, or direct or indirect beneficial ownership, or a combination thereof,
over securities of the Company extends to securities carrying more than 10% of the voting rights attached to all the Company's
outstanding voting securities.

 

Text of Resolution

 

Accordingly, at the Meeting, shareholders will be asked
to pass an ordinary resolution in the following form:

 

RESOLVED to:

 

(a)  
approve the amendment of the Company’s stock option plan pursuant to which the Board of Directors may, from time to time,
grant stock options to directors, officers, employees and consultants of the Company and its subsidiaries (the "Plan")
as follows:

 

(i)   
to increase the number of common shares of the Company reserved for issuance under the Plan (the “Fixed Number”) from
36,326,000 to the greater of 43,551,667 or 20% of the number of issued and outstanding common shares of the Company at the close
of business on the day prior to the day of the Meeting; and

 

(b) (with all Interested
Parties abstaining from voting) to approve the adoption of the 2016 Plan incorporating the aforesaid amendment providing for the
grant of the increased number of options under the Plan and under all other previously established share compensation arrangements.

 

Recommendation of Directors

 

The Board recommends that the holders of Common
Shares vote in favour of the amendments to the Plan and the adoption of the 2016 Plan. Unless otherwise instructed, the
persons named in the

    	 	- 24 -	 

    

    

 

accompanying Proxy (provided the same is duly executed in their favour and is duly deposited) intend
to vote FOR the approval of the Stock Option Plan.

 

ADDITIONAL INFORMATION AND DOCUMENTS INCORPORATED BY
REFERENCE

 

The following documents filed with the securities commissions
or similar regulatory authority of Ontario, Quebec, British Columbia and Alberta are specifically incorporated by reference into,
and form an integral part of, this Information Circular: (i) the financial statements for the year ended December 31, 2015, (ii)
the report of the auditors thereon, (iii) the related management’s discussion and analysis (MD&A), (iv) the Form 20-F
filed on EDGAR as well as on the SEDAR website which constitutes the Company’s Annual Information Form, and (v) any other
documents referred to herein which are filed including:

 

a.        Code of Conduct;

b.        Disclosure Policy;

c.        Securities Trading Policy;

d.        CGNC Charter;

e.        Compensation Committee Charter;

f.         Fraud and Embezzlement Policy; and

g.        Whistleblower and Protected Disclosure Policy

 

Shareholders may contact the Company at Suite 1107, 120 Eglinton
Avenue East, Toronto, Ontario M4P 1E2 to request copies of these documents or download them from the SEDAR website at
<www.sedar.com>.

 

Additional information relating to the Company is also available on SEDAR
or from the Company’s website at <www.poet-technologies.com>.

 

OTHER MATTERS

 

Management of the Company is not aware of any other
matter to come before the Meeting other than as set forth in the notice of Meeting. If any other matter properly comes before the
Meeting, it is the intention of the persons named in the enclosed Proxy to vote the shares represented thereby in accordance with
their best judgment on such matter.

 

DATED this 24th day
of May, 2016.

 

 

	 	APPROVED BY THE BOARD OF DIRECTORS
	 	 
	 	 
	 	 
	 	(signed) “Suresh Venkatesan”, CEO

 

 

 

 

 

 

 

 

 

 

 

    	 	- 25 -	 

    

    

 

APPENDIX “
A”

POET TECHNOLOGIES
INC. (the “Company”)

THE AUDIT COMMITTEE'S CHARTER

 

 

1.   Composition

 

The AC comprises three (3) or more
directors as determined by the Board, each of whom shall be unrelated non-executive directors, free from any relationship that
would interfere with the exercise of his or her independent judgment. The Board shall appoint one of the members of the AC as chairperson.
Such appointment will be for a one (1) year term and will be ratified by the full Board. Each AC member must be, or must become,
within a reasonable period of time after appointment, "financially literate," which qualification shall be determined
by the Board. In addition, at least one (1) AC member shall have accounting or related financial management background/experience.

 

2.   Authority

 

The AC may, at its own initiative or at the request
of the Board, investigate any activity of the Company. All employees are directed to co-operate as requested by members of the
AC. The AC is empowered to retain persons having special competence as necessary to assist the committee in fulfilling its responsibility.

 

3.   Responsibility

 

The AC is to serve as a focal point for communication
between non-committee directors, the independent (external) auditors and the Company’s Management Team as their duties relate
to financial accounting, reporting, and controls. The AC is to assist the Board in fulfilling its fiduciary responsibilities as
to accounting policies and reporting practices of the Company and all subsidiaries, and the sufficiency of auditing relative thereto.
The AC is the Board’s principal agent in assuring the independence of the Company’s independent auditors, the integrity
of financial management, and the adequacy of financial disclosures to shareholders. However, the opportunity for the independent
auditors to meet with individual directors or the entire Board, as needed, is not to be restricted.

 

The Company’s independent (external) auditors
are ultimately accountable to the AC and the Board. The AC and the Board have the ultimate authority and responsibility to select,
evaluate, and nominate the independent (external) auditor to be proposed for any shareholder approval; and where appropriate, to
replace the Company’s independent (external) auditors.

 

4.   Meetings

 

The AC is to meet at least four (4) times per fiscal
year or as many additional times as the committee deems necessary.

 

5.   Attendance

 

A majority of the members of the AC must be present
at all committee meetings and every effort should be made to hold meetings with all members present. As necessary or desirable,
the chairperson may request that members of the Company’s Management Team and representatives of the independent (external)
auditors be present at meetings of the committee.

 

6.   Minutes

 

Minutes of each AC meeting are to be prepared summarizing
the matters discussed.

 

7.   Specific Mandate/Duties

 

	 	a)	Inform  the  independent (external)  auditors and Management Team  that the  independent (external) auditors and the members of the AC may communicate with each other at any time.
	 	 	 
	 	b)	Review with the CEO, CFO and independent (external) auditors, the Company’s policies and procedures to reasonably assure the adequacy of internal accounting and financial reporting controls.

    	 	- 26 -	 

    

    

 

	 	c)	Have familiarity with the accounting and reporting principles and practices applied by the Company in preparing its financial statements and make, or cause to be made, all necessary inquiries of the Management Team and the independent (external) auditors concerning established standards of corporate conduct and performance and any deviations therefrom.
	 	 	 
	 	d)	Review, prior to the annual audit, the scope and general extent of the independent (external) auditor’s audit examinations. The auditors’ fees are to be arranged with the Management Team and annually summarized for the AC’s review and approval.
	 	 	 
	 	e)	Review with the Company’s Management Team the extent of non-audit services planned to be provided by the independent (external) auditors in relation to the objectivity needed in the audit.
	 	 	 
	 	f)	Review with the Company’s Management Team and the independent (external) auditors, upon completion of their audit, financial results and MD&A at year end, together with any related press releases, prior to filing or distribution.
	 	 	 
	 	g)	Evaluate the cooperation received by the independent (external) auditors during their audit examination, including their access to all requested records, data and information, and also inquire of the independent (external) auditors whether there have been any disagreements with the Company’s Management Team, which if not satisfactorily resolved  would  have caused the independent auditors to issue a non-standard report on the Company’s financial statements. Elicit the comments of the Management Team regarding the responsiveness of the independent auditors to the Company’s needs.
	 	 	 
	 	h)	Recommend to the Board whether, based on the reviews and discussions referred to above, the annual financial statements and any related MD&A should be included in the Company’s Annual Report filed on SEDAR, distributed to shareholders and otherwise released.
	 	 	 
	 	i)	Review with the Company’s Management Team and the independent (external) auditors (if required or determined necessary by the AC), interim financial results and MD&A, together with any related press releases, prior to filing or distribution.
	 	 	 
	 	j)	Recommend to the Board whether, based on the reviews and discussions referred to above, the interim financial statements and any related MD&A should be filed on SEDAR, distributed to shareholders and otherwise released.
	 	 	 
	 	k)	Discuss with the independent (external) auditors and the Company’s Management Team the quality of the Company’s financial and accounting personnel and any relevant recommendations the independent auditors (external) may have.
	 	 	 
	 	l)	Discuss any significant changes to the Company’s accounting principles and any items required to be communicated to the independent (external) auditors.
	 	 	 
	 	m)	Review and reassess the adequacy of the AC’s Charter at least annually and submit this same to the Board for approval.
	 	 	 
	 	n)	Ensure that the independent (external) auditors submit, on a periodic basis to the AC, a formal written statement delineating all relationships between the  independent auditors  and  the Company, actively engage in a dialogue with the independent auditors with respect to any disclosed relationships or services that may impact the objectivity and independence of the independent auditors, and recommend that the Board take appropriate action in response to the independent auditors’ report to satisfy itself of the auditors’ independence.
	 	 	 
	 	o)	Recommend to the Board the retention or replacement of the independent auditors.
	 	 	 
	 	p)	Review and approve the Company’s hiring policies regarding partners, employees and former partners and employees of the present and former independent (external) auditors of the Company.
	 	 	 
	 	q)	Apprise the Board, as necessary, through minutes and special presentations of significant developments in the course of performing the above duties.

 

    	 	- 27 -	 

    

    

	 	r)	Approve capital expenditures at levels up to the maximum amount of the AC’s authority as determined by the Board from time to time. Any decisions made by the AC will be reported to the full Board and ratified at its next meeting.
	 	 	 
	 	s)	Recommend to the Board any appropriate extensions or changes in the duties of the AC.
	 	 	 
	 	t)	Establish and monitor  procedures for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or audit matters and the confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters. The AC shall review periodically  with the Company’s Management Team these procedures and any significant complaints received.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-28-Exhibit 4.4

 

 

 

 

 

 

 

 

 

 

 

 

POET

TECHNOLOGIES INC.

 

 

 

 

 

Management’s
Discussion

and Analysis

Year ended December
31, 2015

 

 

 

 

 

	
        NOTE TO READER

         

        This amendment to POET Technologies Inc. (the “Company”) annual Management
        Discussion and Analysis (“MD&A”) for the year ended December 31, 2015, filed on March 17, 2016 which is to be read
        in conjunction with the Company’s audited consolidated financial statements also filed on March 17, 2016 has been amended
        to correct the following statement:

         

        1.   
        Bullet 4 on page 2 – “the realignment of all foundry activities may result in some minor delays in the Company's
        Q1 2017 milestones”

         

        The correction to the above statement is:

         

        1.   
        Bullet 4 on page 2 – “the realignment of all foundry activities may result in some minor delays in the Company's
        Q1 2016 milestones”

         

 

 

 

     

    

    

TABLE OF CONTENTS

 

	Forward Looking Statements 	1
	Business Overview	1
	Semiconductor Technology Process IP	2
	The Company	2
	Industry Outlook	3
	Key Success Drivers (“KSD”)	4
	Significant Events & Milestones During 2015	4
	Summary of Quarterly Results	5
	Explanation of Quarterly Results for the Three Months Ended December 31, 2015	6
	Explanation of Results for the Year Ended December 31, 2015 	6
	Explanation of Material Variations by Quarter for the Last Eight Quarters	8
	Segment Disclosure	10
	ODIS Inc (“ODIS”)	10
	Liquidity and Capital Resources 	11
	Related Party Transactions	11
	Critical Accounting Estimates 	11
	Recent Accounting Pronouncements	12
	Financial Instruments and Risk Management	12
	Exchange Rate Risk	12
	Interest Rate Risk 	12
	World Economic Risk	12
	Liquidity Risk	12
	Strategy and Outlook 	12
	Outstanding Share Data 	13
	Common Shares	13
	Stock Options and Warrants	13
	Off-Balance Sheet Arrangements 	13
	Key Business Risks and Uncertainties 	13
	Additional Information	13

 

    	 - i
                                                                                                                                                                                                                             -

    

    

 

 

 

 

 

		
        POET Technologies Inc.
        

        Suite 501 - 121 Richmond Street West

        Toronto, Ontario, Canada M5H 2K1

        Tel: (416) 368-9411 Fax: (416) 861-0749

 

Management’s Discussion
and Analysis

For the Year Ended December
31, 2015

 

The following discussion and analysis of the operations, results,
and financial position of POET Technologies Inc., (the “Company”) for the year ended December 31, 2015 (the “Year”)
should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31,
2015 and the related notes thereto where applicable, both of which were prepared in accordance with International Financial Reporting
Standards (“IFRS”). The effective date of this report is March 17, 2016. All financial figures are in United States
dollars (“USD”) unless otherwise indicated. The abbreviation “U.S.” used throughout refers to the United
States of America.

 

Forward-Looking Statements

 

This management discussion and analysis contains forward-looking
statements that involve risks and uncertainties. It uses words such as “may”, “would”, “could”,
“will”, “likely”, “expect”, “anticipate”, “believe”, “intend”,
“plan”, “forecast”, “project”, “estimate”, and other similar expressions to identify
forward-looking statements. Forward-looking statements are subject to a variety of risks and uncertainties which could cause actual
events or results to differ from those reflected in the forward-looking statements, including, without limitation, risks and uncertainties
relating to the early stage of the Company’s development and the possibility that future development of the Company’s
technology and business will not be consistent with management’s expectations, difficulties in achieving commercial production
or interruptions in such production if achieved, the inherent uncertainty of cost estimates and the potential for unexpected costs
and expenses, the uncertainty of profitability and failure to obtain adequate financing on a timely basis. The Company undertakes
no obligation to update forward-looking statements if circumstances or Management’s estimates or opinions should change,
except to the extent required by law. The reader is cautioned not to place undue reliance on forward-looking statements.

 

Business Overview

 

We continue to depend on electronics for day-to-day functioning.
As that dependency grows, so does the need for smaller, faster and more power efficient devices. Accordingly, photonics is seeing
a second wave of growth fuelled by these consumers (social networking, cloud computing, Software as a Service (“SaaS”)
etc.) and consumer devices.

 

The tangible impact of the current smart phone revolution is the
explosion in the use of SaaS – this manifests itself in the form of “apps” on the cell phone, but drives the
need for significant background computations, typically carried out in the “cloud”. Social Networking, Cloud Computing,
Internet of Things and the growth of mega-datacenters are galvanizing a renewed spurt of growth in photonics. Investments by Web2.0
companies in mega-datacenters and supporting networking infrastructure have created a new and very dynamic segment in the optical
components and modules market.

 

Moore’s Law continues to drive progress in silicon technology
at the leading edge, although with diminishing returns. A flurry of so called “More than Moore” technologies are now
augmenting conventional silicon technologies in continuing to provide the means for functional integration inherent in the thesis
called Moore’s Law. Optical technologies are now entering the realm of “More than Moore” technologies with a
promise to unlock the interconnect bottlenecks that are increasingly impacting scaled silicon technologies. Specifically, copper
interconnects (commonly used in leading edge semiconductor technologies and printed circuit boards) are increasingly challenged
to sustain the ever increasing bandwidth requirements and are limited reach and power hungry. New optical solutions are being sought
to address this imminent issue.

 

Any processing solution requires two fundamental functions –
computation and communication. Computational efficiencies are addressed with Moore’s Law advances in silicon technologies.
However, communications, and more specifically high bandwidth data communications, are increasingly addressed using optical technology.
To lower the power consumption of leading edge silicon, the industry is in need of new optical technology that augments existing
silicon technologies and provides high bandwidth with low cost optical interconnects, thus unlocking the full potential of the
silicon transistors.

 

Just as cost and power reductions in the world of silicon have been
driven by “integration” – or the ability to put multiple functions on a single chip – similarly, the world
of optics requires an “integration approach” to break the traditional barriers of cost and scalability. Currently,
there have been few technologies that have demonstrated the capability to integrate multiple optical functions on a single chip.

 

    	 	1	 

    

    

The Company has developed a unique, proprietary process that addresses
the deficiencies of size, integration, power and cost efficiency associated with current opto-electronic semiconductor manufacturing
technologies. The novel process can be accommodated in existing semiconductor fabs with minimum re-tooling, thus potentially reducing
capital expenditures required to adopt POET’s process technologies.

 

The Company has a number of issued patents and patents pending related
to the semiconductor Planar Opto-Electronic Technology (“POET”). Currently, the Company’s focus is on the design
of III-V semiconductor devices, processes, and products for data communication applications in the consumer, data center and high
performance computing segments. The POET platform also enables applications in adjacent segments in military, industrial and mobility.

 

The Company is positioned as an opto-electronic product and Intellectual
Property (“IP”) Company, with an aim to leverage existing and potential relationships in establishing a POET design
and manufacturing value chain, and in commercializing POET IP.

 

The Company is incorporated under the laws of the Province of Ontario.
The Company’s shares trade under the symbol “PTK” on the TSX Venture Exchange in Canada and under the symbol
“POETF” on the OTCQX in the U.S.

 

The following sections discuss its business in more detail.

 

Semiconductor Technology Process IP

 

The Company is conducting research and development related to expansion
of the POET platform by adding processes to the POET IP portfolio. It is also engaged in developmental work related to existing
POET processes for data communications applications in potential consumer, data center, high performance computing, industrial,
military and mobility segments. The Company continues to develop gallium arsenide-based processes having several potential market
applications, including: (i) infrared sensor arrays for defense as well as domestic monitoring and imaging applications, (ii) the
unique combination of analog, mixed-signal, digital and optical functions on the same chip for potential use in high volume short
reach and very short reach data communication transceivers and (iii) exploring the use of POET’s unique VCSEL technology
as smart pixels for application in display applications for Augmented Reality. The Company believes that the POET process has the
potential to fundamentally alter the landscape of optical data communications for a broad range of applications by offering unique
integrated optical and electronic components with dramatically lower solutions cost together with increased density, reliability
and lower power consumption through integration.

 

The Company:

 

	1.	Has successfully produced numerous distinct devices using the POET process, including on-chip continuous-wave lasers and switching lasers with the potential for eliminating chip-to-chip metallic interconnects, complementary hetero-structure field effect transistors (HFETs), optical thyristors, and resonant cavity detectors.
	 	 
	2.	Continues to establish Process Design Kits (“PDKs”) with an initial focus on the components essential for the design of monolithically integrated VCSEL based optical transceivers.  PDKs comprise a library of design rules and parameters for the POET technology that can eventually enable POET and its partners to implement the POET fabrication process into their preferred products. 
	 	 
	3.	 Is utilizing Synopsys’ and Coventor’s tools and services to help develop POET PDKs. PDKs will initially be used by POET and its 3rd party chip developers to create integrated opto-electronic transceiver product prototypes.
	 	 
	4.	Is continuing to consider foundry relationships with commercial pure-play 6” foundry suppliers. In 2015, the Company signed a VCSEL Manufacturing Process Transfer agreement with Anadigics for early prototyping and initial development and a Manufacturing Services agreement with Wavetek for long term manufacturing. Wavetek, which is a wholly owned subsidiary of United Microelectronics Corporation (UMC), is a pure-play semiconductor foundry based in Taiwan.  In addition, the Company has signed an epitaxial wafer supply agreement with Epiworks, which is a leading provider of MOCVD wafers to the electronics and optical industry.  These relationships are helping to accelerate the “Lab-to-Fab” transition of the POET technology to a 6" wafer scale. These engagements will provide the baseline process flow in a manufacturing environment and enable the demonstration of product prototypes.  As Anadigics became a takeover target towards the end of the year, the Company decided to de-emphasize its engagement with Anadigics as of the end of 2015 to avoid any potential operational uncertainties.   The Company has placed its focus and priority on developing our technology with Wavetek. The realignment of all foundry activities may result in some minor delays in the Company's Q1 2016 milestones tied to device demonstration.  The Company is working closely with Wavetek to recover the schedules and complete the necessary device demonstrations on time

 

    	 	2	 

    

    

With an immediate view to commercialization, the management team
is focused on exploiting existing high growth markets where the disruptive power of the POET platform IP provides sustained
competitive differentiation.  

 

Industry Outlook

 

Social Networking, Cloud Computing and growth in Mobile are driving
a continuous need for improvements in bandwidth and data handling capacity. This has driven and continues to drive significant
growth in Data Centers. The Cloud Data Center traffic growth is over 25% compound annual growth rate (“CAGR “)[1]
and is expected to continue to grow at this rate for the next few years. Power consumption in Data Centers has now become a huge
central issue. There is a need to proliferate low power computing and communications technology in the Data Centers – and
enable the conversion of the power hungry copper based communication links to Fiber Optics.

 

The Company’s POET technology is applicable to a large portion
of the opto-electronic semiconductor market as it represents an integrated comprehensive solution to increasing the performance
potential of semiconductors in an economical and functional manner. The technology is particularly capable of addressing the power
challenges currently faced in Data Centers. POET provides the potential for revolutionary innovation that enables it to manage
more data at the performance of light but at near the cost points of copper. Based on the Company’s interactions with potential
customers POET may provide significant value in applications where it addresses the need for lower power consumption, solution
size, and cost efficiency.

 

Data centers today are enduring an excruciating pain point in terms
of power. Energy management costs for US data centers alone had approached US$9 billion in 2013 according to the National Resources
Defense Council and are forecast to rise to $13.7 Billion by 2020. Each watt of heat that does not have to be rejected from the
rack could be worth savings in outright direct energy but also in indirect energy related to cooling costs. A single copper direct
attach cable consumes about 3W of power per end. Let’s take a single mega datacenter with between 10,000-100,000 servers
and a rough estimate of potentially 100,000 copper links. If you can save 5W of power per copper link used in this one Data Center,
this can easily translate into 0.5 million Watts of saved energy translating into significant savings in operating expenses for
a single mega data center. We believe data communications, is primed for an integrated opto-electronic device and process platform
that can enable low power, minimized size and component cost. This is the opportunity that POET is targeting to address, with its
patented process that integrates digital, high-speed analog and optical devices on the same chip. We believe that the process can
enable managing data at the speed of light and the cost of copper.

 

The POET platform may provide the following advantages to the industry:

 

	• 	Up to 10X power savings improvement over existing copper technologies (especially for high speed data communication links)
	 	 
	• 	Up to 5X cost improvement over existing optical component solutions
	 	 
	• 	Performance and Power of optical solutions at the price points competitive to that of copper, thus potentially accelerating a transition to optical communications from cumbersome copper links
	 	 
	• 	Flexible and integrated solution that can be applied to virtually any technical application that commands an optical IO for high bandwidth, including chip to chip communications, on-board optics and on-chip optical communications

 

The Company’s strategy is to complete development of its VCSEL
based integrated optical platform and monetize this technology with a mix of product and licensing revenue, while continuing research
towards the expansion of the IP portfolio.

 

The disruptive potential of the POET technology was first recognized
within the military community, and this recognition has remained strong. Applications in this market include infra-red sensor arrays
and high frequency RF Monolithic Microwave Integrated Circuits (“MMIC”’s).

 

 

1 Source: Cisco Global
Cloud Index 2014

 

    	 	3	 

    

    

Key Success Drivers

 

The POET platform, which is covered by numerous patents and patents
pending, if and when fully developed may make possible the economic production of fully-integrated optoelectronic semiconductor
devices with lower cost, smaller form factors and reduced power consumption compared to conventional photonics technologies. The
Company will continue to drive research, as the expansion of the IP portfolio is important to the future of POET. The currently
developed integrated VCSEL technology is in its early development stage and is being transferred to a commercial manufacturing
source where development and qualification is expected to be completed in 2016. The success of early stage semiconductor companies
is highly dependent on their ability to identify milestones that push the limit of existing technology and the achievement of those
milestones in a timely fashion. The Company has demonstrated such successes in the past and continues to establish and achieve
significant milestones. Significant milestones achieved over the last 3 years include:

 

	1)	Achieving radio frequency and microwave operation of both n-channel and p-channel transistors.  By reaching this milestone, 3-inch POET wafers fabricated at BAE Systems (Nashua, NH) yielded submicron n-channel and micron-sized p-channel transistors operating at frequencies of 42 GHz and 3 GHz respectively.
	 	 
	2)	The integration of the complementary inverter. Specifically, the Company successfully demonstrated complementary heterostructure field effect transistor based inverter operation using the POET process. 
	 	 
	3) 	The fabrication of infrared (IR) detectors, using its proprietary planar optoelectronic technology (POET) platform.  Adding to its significance is the fact that the POET wafers used for the IR devices were fabricated within an independent foundry, BAE Systems’ Microelectronics Center in Nashua, New Hampshire. This milestone represents the integration by a third party of the optoelectronic process previously demonstrated in POET laboratories.
	 	 
	4) 	Demonstration of a two terminal Thyristor VCSEL – which is a key optical engine in the creation of single chip opto-electronic transceivers and changes the current paradigm of analog lasers and detectors. 
	 	 
	5) 	Demonstration of a two terminal resonant cavity Detector – which is also a critical device component used in its optical transceiver products.

 

Timely capital investment is also key to the success of semiconductor
companies. The Company has purchased and installed $1,400,000 of new equipment since 2013. Substantial capital investment is not
anticipated in 2016. The Company’s strategy has been a transition of technology development to third party foundries. Capital
spend in 2016 will be limited to augmenting the test and characterization capabilities of the Company in its new lab in San Jose,
CA.

 

The Company has successfully raised over CA$17.5 million in equity
financing through private placements and an additional CA$26.4 million through the exercise of stock options and warrants since
June 2012 of which CA$15.2 million was raised through the exercise of stock options and warrants in 2015.

 

During 2014, the University of Connecticut converted certain royalty
rights into a significant investment in the Company. The parties agreed to restructure the payment provisions of the licensing
agreement between the Company and the University of Connecticut regarding certain aspects of the POET technology (the “License
Agreement”) by reducing royalty payments to three percent (3%) of amounts received from unaffiliated third parties in respect
of the exploitation of the Intellectual Property defined in the License Agreement, in consideration for 2,000,000 common shares
of the Company.

 

The Company recently established an office in Silicon Valley, San
Jose, California. It is important for the Company to have a presence in the Valley as it is an area of concentration of the potential
customers and partners of the Company.

 

The Company’s future success will also depend on critical
human capital. In this regard, the Company appointed a Chief Operating Officer and Chief Executive Officer in Q2’2015 and
other key members of the operations team in Q4’2015. Three new board members were also appointed in 2015 with unique industry
insight and experience. The Company has also launched a recruitment drive for other key executives and engineering personnel.

 

 

Significant Events and Milestones During 2015

 

In 2015, the Company continued to execute on its stated strategic
plan. The Company has achieved the following significant milestones in 2015:

 

	1.	On February 10, 2015, the Company announced the completion of a significant interim milestone, the completion of the installation of the critical unit processes required by the Transistor Fabrication Process at its 3rd Party Foundry. This provided the substantiation that the process was transferable and scalable to commercial manufacturing sites.
	 	 
	2.	On March 30, 2015, the Company signed an agreement with BAE Systems under which BAE Systems could provide non-exclusive third-party foundry services in support of the Company’s “Lab-to-Fab” transition plan.  At present, there has not been any joint process development or transfer under this agreement, and none is anticipated in the future.
	 	 
	3.	On April 8, 2015, the Company announced the appointment of two new Directors: Todd A. DeBonis and David E. Lazovsky.

    	 	4	 

    

    

 

	 	Mr. DeBonis was the Vice President of Global Sales and Strategic Development at TriQuint Semiconductor, Inc.  Mr DeBonis played an integral role in the merger of RF Micro Devices, Inc. with TriQuint and the subsequent creation of Qorvo, Inc. (Nasdaq: QRVO). Mr. DeBonis was VP Worldwide sales and marketing at Centillium Communications, Ishoni Networks and Infineon Technologies North America.
	 	 
	 	Mr. Lazovsky is the founder of Intermolecular, Inc. (NASDAQ: IMI) and served as President and CEO from 2004 to 2014. Mr. Lazovksy raised significant amounts of venture capital and other strategic private investments in Intermolecular’s initial public offering.  Mr. Lazovsky held senior management roles at Applied Materials Inc. (NASDAQ: AMAT) from 1995 to 2004.  As of March 31, 2014, Mr. Lazovsky held 41 pending or issued U.S. patents.
	 	 
	4.	On April 27, 2015, the Company announced the appointment of Dr. Subhash Deshmukh as Chief Operating Officer effective June 8, 2015.  Dr. Deshmukh was VP Emerging Technologies and Products at Applied Materials Inc. Nasdaq: AMAT) He was also VP and General Manager of the Plasma products Business Unit as well as VP Business Development for Varian Semiconductor Equipment Associates Inc. (NASDAQ: VSEA). Dr.  Deshmukh holds a PhD in Chemical Sciences and has authored or co-authored over 55 technical articles.  Dr. Deshmukh has been granted over 27 patents and several patents pending.
	 	 
	5.	On June 11, 2015, the Company announced the appointment of Dr. Suresh Venkatesan as CEO. Dr. Venkatesan was most recently Senior Vice President, Technology Development at GLOBALFOUNDRIES and was responsible for the company's Technology Research and Development. Dr. Venkatesan joined GLOBALFOUNDRIES in 2009, where he led the development and ramp up of the 28nm node and was instrumental in the technology transfer and qualification of 14nm. In addition, he was responsible for the qualification and ramp up of multiple mainstream value added technology nodes.
	 	 
	6.	On June 15, 2015, the Company announced the appointment of Mohan Warrior as a Director.  Mr. Warrior has been president and chief executive officer (CEO) of Alfalight Inc. (“Alfalight”) since February 2004. Alfalight is a GaAs based high power diode laser manufacturing company with headquarters in Madison, Wisconsin. Alfalight serves military, telecom and industrial customers. Mr. Warrior established Alfalight as a leading provider of high powered laser diode solutions in both commercial and defense segments.  Prior to joining Alfalight, Mr. Warrior's career included 15 years at Motorola Semiconductors (now Freescale) where he led the test and assembly operations, a group of 3500 employees, in the US, Scotland and Korea.
	 	 
	7.	On August 24, 2015, the Company announced a VCSEL Manufacturing Process Transfer Agreement with Anadigics, Inc. to carry out initial development of the POET platform and more specifically VSCELs. This agreement was intended to accelerate the transition from lab-to-fab and enables successful prototype demonstrations in a mature and capable manufacturing environment.
	 	 
	8.	On September 30, 2015, the Company hosted an investor conference call in which it provided an update on the Company’s operational roadmap.
	 	 
	9.	On November 1, 2015, the Company announced the appointment of Robert Ferri Partners, LLC, as the Company’s Investor Relations counsel.
	 	 
	10.	On November 20, 2015, a Manufacturing Services agreement with Wavetek for long term manufacturing was signed.  Wavetek has been retained to complete the goal of a successful prototype demonstration for a product produced in a mature and capable manufacturing environment, specifically focused on the Company’s VCSEL technology.

  

Summary of Quarterly Results

 

Following are the highlights of financial data of the Company for
the most recently completed eight quarters which have been derived from the Company’s consolidated financial statements prepared
in accordance with IFRS:

 

	 	 	 Dec.
    31/15	 	 Sep.
    30/15	 	 Jun.
    30/15	 	Mar. 31/15	 	 Dec.
    31/14	 	 Sep.
    30/14	 	Jun.
    30/14	 	Mar.
    31/14
	Other (income)	 	$	-	 	 	$	-	 	 	$	-	 	 	$	-	 	 	$	-	 	 	$	-	 	 	$	(85,204	)	 	$	(84,628	)
	Shares issued for the reduction of license fee	 	 	-	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	1,439,898	 	 	 	-	 
	Research and development	 	 	932,618	 	 	 	767,124	 	 	 	715,732	 	 	 	564,602	 	 	 	457,470	 	 	 	504,131	 	 	 	362,848	 	 	 	312,302	 
	Depreciation and amortization	 	 	83,526	 	 	 	82,022	 	 	 	79,587	 	 	 	74,728	 	 	 	70,222	 	 	 	66,050	 	 	 	50,276	 	 	 	50,407	 
	Professional fees	 	 	225,118	 	 	 	110,389	 	 	 	353,892	 	 	 	122,716	 	 	 	134,339	 	 	 	325,695	 	 	 	146,057	 	 	 	301,703	 
	Wages and benefits	 	 	414,857	 	 	 	423,214	 	 	 	269,015	 	 	 	198,965	 	 	 	578,071	 	 	 	405,012	 	 	 	366,368	 	 	 	351,149	 
	Management and consulting fees	 	 	156,154	 	 	 	160,303	 	 	 	168,700	 	 	 	180,614	 	 	 	140,040	 	 	 	290,327	 	 	 	65,084	 	 	 	100,216	 
	Stock-based compensation (1)	 	 	1,491,713	 	 	 	1,621,751	 	 	 	1,110,758	 	 	 	593,898	 	 	 	1,044,330	 	 	 	2,613,335	 	 	 	368,558	 	 	 	589,774	 
	General and administrative	 	 	353,399	 	 	 	285,802	 	 	 	241,088	 	 	 	364,316	 	 	 	204,857	 	 	 	192,935	 	 	 	224,892	 	 	 	199,286	 
	Investment (income), including interest	 	 	(20,188	)	 	 	(18,979	)	 	 	(22,793	)	 	 	(14,471	)	 	 	-	 	 	 	-	 	 	 	-	 	 	 	-	 
	Net loss	 	$	3,637,197	 	 	$	3,431,626	 	 	$	2,915,979	 	 	$	2,085,368	 	 	$	2,629,329	 	 	$	4,397,485	 	 	$	2,938,777	 	 	$	1,820,209	 

 

	(1)	Stock based
    compensation allocated between General and Administrative and Research and Development issuances is combined for MD&A
    purposes. For financial statement presentation purposes, stock based compensation is split between General and Administrative
    and Research and Development.

 

    	 	5	 

    

    

Explanation of Quarterly Results for the three months ended
December 31, 2015 ("Q4 2015")

 

During Q4 2015, the Company reported a loss of $3,637,197 as compared
to a loss of $2,629,329 for the same period in 2014. The following discusses the significant variances between Q4 2015 and the
three months ended December 31, 2014 ("Q4 2014").

 

Consistent with the strategy of the Company and its goal of monetizing
POET, Research and development (“R&D”) increased by 104% or $475,148 over the same period in 2014 from $457,470
to $932,618. The increase is attributed primarily to subcontract fees related to the Company’s research and development program
which increased by 257% or $433,282 from $168,704 in Q4 2014 to $601,986 in Q4 2015. In Q4 2015 additional costs associated with
new established foundry and technology development relationships with companies like Anadigics Inc., Epiworks Inc. and Intelligent
Epitaxy Technology to expedite the technology development were incurred over the same period in the prior year.

 

The Company closed its Uconn facilities in Q4 2015. The strategy
for closing the Uconn lab was to outsource the technology development to labs that are more modern with equipment that has the
capability to handle the Company’s advanced technology, a continuation of the Company’s path from Lab to Fab.

 

Professional fees increased by $90,779 or 68% from $134,339 in Q4
2014 to $225,118 in Q4 2015. The increased fees were a result of legal fees associated with the expansion of the Company’s
patent portfolio coverage in a number of foreign jurisdictions. The Company also spent additional fees on professional services
involved in testing the efficiency of the Company’s internal controls as required by the Sarbanes Oxley Act of 2002.

 

Wages and benefits decreased by $163,214 or 28% from Q4 2014 to
Q4 2015. In Q4 2014, the Company paid performance bonuses of $230,000 to the former interim CEO and former COO. No bonuses were
paid in Q4 2015.

 

General and administrative increased in Q4 2015 by $148,542 over
the same period in 2014. This increase was primarily due to the $30,144 increase in rent expense due to the addition of the Company’s
new location in Silicon Valley and the $41,000 increase in investor relations and travel expenses. The Company also incurred $26,000
in the quarter related to the costs of closing the Uconn lab and moving equipment and other assets to the new Silicon Valley location.
The increased costs ensured an orderly transition with no loss of valuable development time or know-how.

 

Non-cash stock-based compensation had the most significant increase
from Q4 2014 to Q4 2015. This expense increased by $447,383 from $1,044,330 in Q4 2014 to $1,491,713 in Q4 2015. The valuation
of stock options is driven by a number of factors including the quantity of options granted, the strike price and the volatility
of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization
of the options as they vest.

 

The stock options vest in accordance with the policies determined
by the Board of Directors from time to time consistent with the provisions of the 2015 Plan which grants discretion to the Board
of Directors.

 

Explanation of Results for the Year Ended December 31, 2015

 

During the year ended December 31, 2015, the Company recorded a
loss of $12,070,170 compared to a loss of $11,785,800 for the year ended December 31, 2014. Changes in major expense categories
are discussed below:

 

SBIR Grant Income

The Company had $169,832 in SBIR grant income for the year ended
December 31, 2014. During 2014 the Company decided to eliminate its use of SBIR grants in order to focus all of its resources on
developing and monetizing the POET technology. The Company had no SBIR grant income for the year ended December 31, 2015.

 

Research and Development.

During the year ended December 31, 2015 $2,980,076 was spent on
R&D, of this amount, $1,560,819 was spent on subcontract services as compared to $582,943 in fiscal 2014. The subcontract fees
related to work done with the Company’s VCSEL technology, epitaxy substrates and technical design kits. This development
process required the use of third party consultants to both test and prove the concepts. During the year ended December 31, 2015,
the Company expanded on its development roadmap which included additional proof of concept tests conducted by the Company’s
then primary R&D consultant, Anadigics, Inc. The Company also engaged other R&D services providers such as Epiworks Inc.,
Intelligent Epitaxy Technology and Wavetek to expand the technology development. The Company has transitioned to an outsourcing
model to expedite the development process. This transition is part of the Company’s ultimate objective of working with a
“pure-play” foundry offering a wide range of dedicated, flexible and competitive foundry services. Additionally, in
early 2015, the Company had expanded the capacity of the work being undertaken by BAE but stopped this activity in the second half
of 2015 with a transition to Anadigics. BAE was the Company’s primary subcontractor in 2014, most of the subcontract fees
for that year were spent on services provided by BAE.

 

    	 	6	 

    

    

R&D wages during the year ended December 31, 2015 increased
by 38% or $341,296 over 2014. The increase in wages relate to the addition of a CTO and Program Manager along with additional over-time
hours. These new employees were not with the Company in 2014. In addition, improper installation of equipment which was purchased
in 2014 contributed to the team working significant over time hours to identify the cause of poor test results generated by this
piece of equipment. The issues relating to the faulty installation were rectified in the first quarter of 2015. The increase is
consistent with the Company’s 2015 budget.

 

Management and Consulting Fees

Management and consulting fees increased for the year ended December
31, 2015 by $70,104 over 2014. The increase was mainly due to the compensation of the Executive Co-Chairman who joined the Company
in July 2014. The Company had some reduction in consulting fees due to discontinuing services that the Company felt were not adding
material value.

 

General and Administrative

General and administrative increased by $422,635 for the year ended
December 31, 2015 over 2014. The increase is primarily due to increased investor relations, travel and promotion, which collectively
increased by $255,000. The Company implemented a promotion program for POET which included advertisements on Bloomberg TV and the
Fox News Network. The Company also had its annual general meeting in Silicon Valley which resulted in increased logistics costs.
Multiple Asian trips in securing new opportunities with potential service providers and partners increased the travel costs during
the year over 2014.

 

Additionally, maintenance and repair costs, included in general
and administrative, increased by $25,000 for the year ended December 31, 2015 over 2014. These costs resulted primarily from the
improper installation of new equipment by a third party. The Company consulted with specialists in the field to assist with correcting
the issues related to the faulty installation. The issues relating to the faulty installation were rectified in the first quarter
of 2015. The Company also spent $17,000 on specialized software that was required to operate the equipment along with optimizing
the optical elements of the POET process.

 

Rent expense increased by approximately $73,000 over 2014 due to
the addition of the Company’s new location in Silicon Valley.

 

Wages and Benefits

Wages and benefits decreased by $394,549 from 2014 to 2015 as a
result of the cessation of employment of the former president in September 2014 and the non-repetition of 2014 performance bonuses
of $337,000 paid to the former interim CEO and former COO. The compensation to the former president included a one-time debt settlement
of $100,000 which was settled in February 2014. Wages and benefits will, however, increase over the short-term with the addition
of the new CEO and COO, and the transition of responsibilities between the CEO and former interim CEO. While the Company experienced
decreases relating to bonuses paid to the former interim CEO and wages payable to the former president, there was a partial offsetting
due to the addition of the new COO and CEO salaries.  

 

Professional Fees

Professional fees decreased by 11% from $907,794 in 2014 to $812,115
in 2015. Professional services in 2015 were primarily on routine operational matters as compared to 2014 when the Company incurred
additional fees for the updated Pellegrino valuation report which indicated a median value for the Company of approximately $2.3
billion. Additionally, increased fees were incurred in 2014 for submitting a registration statement on Form 20-F in connection
with the registration of its common stock under the U.S. Securities Exchange Act of 1934.

 

Non-Cash Stock-based Compensation

Non-cash stock-based compensation increased by $202,123 from $4,615,997
in 2014 to $4,818,120 in 2015. The Company granted 11,655,000 stock options during the year ended December 31, 2015 as compared
to 6,155,000 in 2014. The number of options granted for the year ended December 31, 2015 were unusually high due to the recruitment
of two new senior executive officers. The valuation of stock options is driven by a number of factors including the quantity of
options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the
timing of the stock option grant and the amortization of the options as they vest.

 

The stock options vest in accordance with the policies determined
by the Board of Directors from time to time consistent with the provisions of the 2015 Plan which grants discretion to the Board
of Directors.

 

    	 	7	 

    

    

Shares issued for the reduction of license fee

For the year ended December 31, 2014, the Company had a one-time
non-cash issuance of 2,000,000 common shares to the University of Connecticut valued at $1,439,898 for the reduction of certain
royalty rights in exchange for an investment in the Company. The parties agreed to restructure the payment provisions of the License
Agreement by reducing royalty payments to three percent (3%) of amounts received from unaffiliated third parties in respect of
the exploitation of the Intellectual Property defined in the License Agreement, in consideration for 2,000,000 common shares of
the Company. The Company did not have a similar expense for the year ended December 31, 2015.

 

Explanation of Material Variations by Quarter for the Last
Eight Quarters

 

Q4 2015 compared to Q3 2015

 

In Q4 2015, professional fees increased by $114,729 over Q3 2015
due to the legal fees incurred relating to the expanded coverage of the Company’s patent portfolio and additional fees related
to testing the effectiveness of the Company’s internal controls as required by the Sarbanes Oxley Act.

 

General and administrative increased by $67,557 in Q4 2015 as compared
to Q3 2015 due to the increase in investor relations and travel during the quarter. The Company engaged in a European road show
in November 2015 to generate interest in the Company and its technology. Additionally, the Company incurred moving and travel costs
associated with the closure of the Uconn facilities.

 

In Q4 2015, the costs associated with new established foundry and
technology development relationships with companies like Anadigics Inc., Epiworks Inc. and Intelligent Epitaxy Technology to expedite
the technology development were incurred. The Company incurred costs of $449,200 relating to these new parties on the expedited
technology work being done as compared to $290,215 in Q3 2015.

 

In Q4 2015, non-cash stock-based compensation decreased by $130,038
from Q3 2015. This is a result of the timing of stock based compensation expense relative to the vesting date of the historical
granted stock options. The valuation of stock options is driven by a number of factors including the quantity of options granted,
the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock
option grant and the amortization of the options as they vest.

 

Q3 2015 compared to Q2 2015

 

In Q3 2015, professional fees decreased by $243,503 from Q2 to Q3
2015. The Company successfully recruited two high profile executive officers (CEO and COO). The Company paid $200,000 in recruitment
fees related to Drs. Deshmukh’s and Venkatesan’s employment in Q2. Both executives were appointed in June 2015. No
recruitment fees were paid in Q3 2015.

 

Wages and benefits increased by $154,199 due to the addition of
the new CEO and COO. Wages and benefits will be higher over the short term as the transition of responsibilities continues from
the former interim CEO to the new CEO as both salaries are incurred by the company in the transition period.

 

Non-cash stock-based compensation in Q3 2015 was $510,993 higher
than the expense in Q2 2015. The increase was impacted by timing of the expense related to the 10,430,000 stock options granted
in 2015. The Company granted 7,857,000 stock options to new executives (CEO and COO). The valuation of stock options is driven
by a number of factors including the quantity of options granted, the strike price and the volatility of the Company’s stock.
The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest.

 

Q2 2015 compared to Q1 2015

 

In Q2 2015, professional fees increased by $231,176 over Q1 2015.
The Company successfully recruited two high profile executive officers (CEO and COO). The Company paid $200,000 in recruitment
fees in Q2 related to Drs. Deshmukh’s and Venkatesan’s employment. Both executives were appointed in June 2015.

 

In Q2 2015, the Company increased its R&D efforts. Additional
consultants were engaged by the Company. The $151,130 increase in R&D, is partially comprised of an additional $60,000 in consulting
fees during Q2 in excess of Q1. The remaining increase was a result of the expanded scope of BAE’s foundry services to the
Company.

 

    	 	8	 

    

    

General and administrative in Q2 2015 was $241,088 as compared to
$364,316 in Q1 2015, a decrease of $123,228. In Q1 2015, the Company increased its investor relations, travel and promotion. The
Company implemented a promotion program for POET which included advertisements on Bloomberg TV and the Fox News Network, which
was expensed solely in Q1. Additionally, there were increases in maintenance and repair costs, resulting from the improper installation
of new equipment by a third party and the purchasing of $15,000 of specialized software required to optimize the optical elements
of the POET process.

 

Non-cash stock-based compensation in Q2 2015 was $516,860 in excess
of the expense in Q1 2015. The increase was impacted by 9,930,000 stock options granted in Q2 as compared to 500,000 granted in
Q1 2015. The Company granted 7,857,000 stock options to new executives (CEO and COO) in Q2. The valuation of stock options are
driven by a number of factors including the quantity of options granted, the strike price and the volatility of the Company’s
stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they
vest.

 

Q1 2015 compared to Q4 2014

 

In Q1 2015, research and development expenses increased by $107,132
over Q4 2014 due to the addition of a Program Manager in Q1 2015 along with substantial overtime incurred during the quarter in
connection with the rectification of improper installation of new equipment as previously discussed. The issues relating to the
improper installation were rectified in Q1 2015.

 

Wages and benefits in Q1 2015 were $198,965 compared to $578,071
in Q4 2014. Q4 2014 included $230,000 paid in bonuses and $165,000 paid in directors fees. No bonuses were paid in Q1 2015 and
director fees consisted of $39,981 in Q1 2015. The director fees in Q4 2014 included an expense for two quarters (Q3 payment and
Q4 accrual).

 

In Q1 2015, non-cash stock-based compensation decreased by $450,432
from Q4 2014. This is a result of the timing of stock based compensation expense relative to the vesting date of the historical
granted stock options The valuation of stock options is driven by a number of factors including the quantity of options granted,
the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock
option grant and the amortization of the options as they vest.

 

In Q1 2015, general and administrative increased by $159,459 over
Q4 2014 due to increased investor relations, travel and promotion in this period. The Company implemented a promotion program for
POET which included advertisements on Bloomberg TV and the Fox News Network which was expensed solely in Q1. Additionally, increases
were incurred in maintenance and repair costs, resulting from the improper installation of new equipment by a third party and the
leasing of specialized software required to optimize the optical elements of the POET process.

 

Q4 2014 compared to Q3 2014

 

Stock-based compensation and professional fees both decreased significantly
from Q3 2014 to Q4 2014. Stock based compensation was $2,613,335 in Q3 2014 compared to $1,044,330 in Q4 2014. The valuation of
stock options is driven by a number of factors including the quantity of options granted, the strike price and the volatility of
the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of
the options as they vest.

 

Professional fees were $325,695 in Q3 2014 compared to $134,339
in Q4 2014. In Q3, the Company updated the Pellegrino valuation report. Additionally, professional fees were incurred in recruiting
the new Executive Co-Chairman in Q3 2014.

 

Wages and benefits increased by $173,214 from Q3 2014 to Q4 2014,
due primarily to a performance bonus of $230,000 paid to the former interim CEO and former COO of the Company.

 

Q3 2014 compared to Q2 2014

 

Professional fees increased by $179,638 from Q2 2014 to Q3 2014.
The increase was primarily due to the updated Pellegrino valuation report and the professional fees incurred in recruiting the
new Executive Co-Chairman.

 

In Q3 2014, non-cash stock-based compensation increased by $2,244,797
over Q2 2014 as a result of the 3,940,000 annual Company stock options granted in Q3 compared to 215,000 granted in Q2 2014. The
valuation of stock options is driven by a number of factors including the quantity of options granted, the strike price and the
volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the
amortization of the options as they vest.

 

In Q2 2014, the Company had a one-time non-cash issuance of 2,000,000
common shares to the University of Connecticut valued at $1,439,898 for the reduction of certain royalty rights in exchange for
an investment in the Company. The parties agreed to restructure the payment provisions of the License Agreement by reducing royalty
payments to three percent (3%) of amounts received from unaffiliated third parties in respect of the exploitation of the Intellectual
Property defined in the License Agreement, in consideration for 2,000,000 common shares of the Company.

 

    	 	9	 

    

    

In Q3 2014, management and consulting fees increased by of $150,000
due primarily to the consulting services provided by a firm for the recruitment of the executive co-chair.

 

Q2 2014 compared to Q1 2014

 

Professional fees decreased from $301,703 in Q1 2014 to $146,057
in Q2 2014. The decrease in professional fees was a result of reduced professional services resulting from the successful completion
of the filing of Form 20-F in Q1 with the SEC to register the Company’s shares in the United States. Additional accounting
fees associated with the annual financial statements were also incurred in Q2.

 

In Q2 2014, non-cash stock-based compensation decreased by $221,216
from Q1 2014. This is a result of the timing of stock based compensation expense relative to the vesting date of the historical
granted stock options. The valuation of stock options is driven by a number of factors including the quantity of options granted,
the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock
option grant and the amortization of the options as they vest.

 

Segment Disclosure

 

The Company and its subsidiaries currently operate in a single segment
- the design of semi-conductor products for military and industrial applications. The Company’s sole operating and reporting
segment reflects the management reporting structure of the organization and the manner in which the chief operating decision maker
regularly assesses information for decision making purposes, including the allocation of resources. A summary of the Company's
operating segment is below:

 

ODIS Inc. (“ODIS”)

ODIS is the developer of the POET platform semiconductor process
IP for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single die.

 

The Company operates geographically in the United States and Canada.
Geographical information is as follows:

 

	 	 	2015
	As of December 31,	 	US	 	Canada	 	Consolidated
	Current assets	 	$	3,055,947	 	 	$	11,504,972	 	 	$	14,560,919	 
	Property and equipment	 	 	924,443	 	 	 	22,664	 	 	 	947,107	 
	Patents and licenses	 	 	426,813	 	 	 	-	 	 	 	426,813	 
	Total Assets	 	$	4,407,203	 	 	$	11,527,636	 	 	$	15,934,839	 

 

	 	 	US	 	Canada	 	Consolidated
	For the year ended December 31,	 	 	 	 	 	 	 	 	 	 	 	 
	General and administration	 	$	6,622,514	 	 	$	1,991,595	 	 	$	8,614,109	 
	Research and development	 	 	3,532,492	 	 	 	-	 	 	 	3,532,492	 
	Investment income	 	 	-	 	 	 	(76,431	)	 	 	(76,431	)
	Net Loss	 	$	10,155,006	 	 	$	1,915,164	 	 	$	12,070,170	 

 

 

	 	 	2014
	As of December 31,	 	US	 	Canada	 	Consolidated
	Current assets	 	$	3,106,274	 	 	$	8,425,091	 	 	$	11,531,365	 
	Property and equipment	 	 	1,054,636	 	 	 	4,224	 	 	 	1,058,860	 
	Patents and licenses	 	 	260,721	 	 	 	-	 	 	 	260,721	 
	Total Assets	 	$	4,421,631	 	 	$	8,429,315	 	 	$	12,850,946	 

 

	 	 	US	 	Canada	 	Consolidated
	For the year ended December 31,	 	 	 	 	 	 	 	 	 	 	 	 
	General and administration	 	$	5,827,262	 	 	$	3,850,443	 	 	$	9,677,705	 
	Research and development	 	 	2,277,927	 	 	 	-	 	 	 	2,277,927	 
	Other income	 	 	(169,832	)	 	 	-	 	 	 	(169,832	)
	Net Loss	 	$	7,935,357	 	 	$	3,850,443	 	 	$	11,785,800	 

 

Note: Certain prior amounts
have been reclassified to conform to the current year’s presentation

 

    	 	10	 

    

    

Liquidity and Capital Resources

 

The Company had working capital of $14,045,498 on December 31, 2015
compared to $11,079,641 on December 31, 2014. The increase and maintenance of the higher working capital was due to the approximately
$12.1 million dollars raised through the exercise of stock options and warrants during the year ended December 31, 2015.

 

The Company’s balance sheet as at December 31, 2015 reflects
assets with a book value of $15,934,836 (2014 - $12,850,946) of which 91% (2014 - 89%) or $14,560,919 (2014 - $11,531,365) is current
and consists primarily of cash totaling $14,409,996 (2014 - $11,287,864). The Company’s liquidity and unencumbered balance
sheet will allow for investments in capital equipment and valuable human capital which are necessary to enable the Company to achieve
its technical and operational milestones.

Based on current plans and cash utilization, we believe we have
sufficient liquidity to support our operations and technological programs beyond the end of 2016, which include further development
of the POET semiconductor process and increasing the POET intellectual property portfolio to enable us to exploit POET, through
licenses and collaborative arrangements.

 

The Company expects to increase its research and development program
in the short term to advance the POET process, this will result in increased subcontractor fees expense for 2016.

 

The Company is embarking on an aggressive plan of attempting to
monetize POET while simultaneously improving shareholder value. The focus, therefore, is to remain sufficiently capitalized to
facilitate this.

 

Subsequent to December 31, 2015, the Company received $1,965,327
from the exercise of 2,686,947 warrants and 628,000 stock options.

 

Related Party Transactions

 

Compensation to key management personnel were as follows:

 

	December 31.	 	2015	 	2014
	Salaries	 	$	1,979,601	 	 	$	1,363,417	 
	Share-based payments (1)	 	 	3,283,361	 	 	 	1,167,245	 
	Total	 	$	5,262,962	 	 	$	2,530,662	 

 

(1)      
Share-based payments are the fair value of options granted to key management personnel and expensed during the year as calculated
using the Black-Scholes model.

During the year ended December 31, 2014, the Company settled $100,000
that was advanced to the former CEO of the Company. The amount was non-interest bearing and short-term in nature. The Company settled
the amount due from the former CEO in return for a reduction in his compensation and certain other entitlements.

 

In 2014, the former CEO of the Company received a severance package
of $185,000 to be paid over one year. The full amount of the severance package was accounted for in 2014.

 

The Company paid or accrued $104,790 in fees and disbursements for
the year ended December 31, 2015 (2014 - $174,549) to a law firm, of which a director is counsel, for legal services rendered to
the Company.

 

All transactions with related parties have occurred in the normal
course of operations and are measured at the exchange amounts, which are the amounts of consideration established and agreed to
by the related parties.

 

Critical Accounting Estimates

 

Stock-based Compensation

Stock options and warrants awarded to non-employees are accounted
for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Stock options and
warrants awarded to employees are accounted for using the fair value method. The fair value of such stock options and warrants
granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant.
The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.

 

    	 	11	 

    

    

Other stock-based payments

The Company accounts for other stock-based payments based on the
fair value of the equity instruments issued or service provided, whichever is more reliable.

 

Cumulative Translation Adjustment

IFRS requires certain gains and losses such as certain exchange
gains and losses arising from the translation of the financial statements of a self-sustaining foreign operation to be included
in comprehensive income.

 

Recent Accounting Pronouncements

 

The Company has considered all recently issued accounting pronouncements
and does not believe the adopting of such pronouncements will have a material impact on its consolidated financial statements.
Please see note 3 of the financial statements for additional information.

 

Financial Instruments and Risk Management

 

The Company's financial instruments consist of cash and accounts
payable and accrued liabilities. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant
interest or credit risks arising from these financial instruments. The Company estimates that the fair value of these instruments
approximate the carrying values due to their short term nature.

 

Exchange Rate Risk

 

The Company is exposed to foreign currency risk with the Canadian
dollar. The Company maintains bank accounts and cash reserves in both currencies with the majority of reserves currently in Canadian
dollars which has exposure to currency fluctuations. Most of the company’s operations are transacted in US dollars. A 10%
change in the Canadian dollar would increase or decrease other comprehensive loss by $1,135,639.

 

Interest Rate Risk

 

Cash equivalents bear interest at fixed rates, and as such, are
subject to interest rate risk resulting from changes in fair value from market fluctuations in interest rates. The Company does
not depend on interest from its investments to fund its operations.

 

World Economic Risk

 

Like many other companies, the world economic climate could have
an impact on the Company's business and the business of many of its current and prospective customers. A slump in demand for electronic-based
devices, due to a world economic crisis, may impact any anticipated licensing revenue.

 

Liquidity Risk

 

The Company predominately relies on equity funding for liquidity
to meet current and foreseeable financial requirements.

 

Strategy and Outlook

 

There are a number of projects planned for 2016 which the Company
expects will address the short-term and long-term growth plans of the Company including, but not limited to the following:

 

	• 	Continue to expand and develop the POET technology platform.
	 	 
	• 	Re-profile the current engineering team as critical lab activities transitioned out of the lab into a commercial foundry environment. 
	 	 
	• 	Expand the POET executive team, through an ongoing executive recruiting program, which includes amongst other positions a VP, Technology Development and various positions listed on the POET careers website [http://www.poet-technologies.com/careers].
	 	 
	• 	Procure additional equipment which may be required for the continuing development and expansion of the POET platform.
	 	 
	• 	Continue to develop and expand the IP patent portfolio.

 

    	 	12	 

    

    

	• 	Facilitate the adoption of the POET process into opto-electronic products by providing ease of access to the platform with initiatives such as the development of the PDKs.
	 	 
	• 	Continue the lab-fab transition through ongoing evaluation of external partners for both the epi stack growth and commercial foundry fabrication.
	 	 
	• 	Actively search out opportunities to monetize POET.

 

Outstanding Share Data

 

Common Shares

As of December 31, 2015 and March 17, 2016, there were respectively,
197,097,815 and 200,412,762 outstanding common shares of the Company.

 

Stock Options and Warrants

As of December 31, 2015, there were 8,369,233 warrants and compensation
warrants outstanding to purchase common shares at exercise prices ranging from CA$0.23 – CA$1.00.

 

As of March 17, 2016, there were 1,116,051 compensation warrants
outstanding to purchase common shares at an exercise price of CA$0.23.

 

Total stock options outstanding as at December 31, 2015 and March
17, 2016, were 26,718,500 and 26,045,500 priced between CA$0.23 and CA$1.99 per common share.

 

Additional detailed share data information is available the Company’s
Notes to Consolidated Financial Statement.

 

Off-Balance Sheet Arrangements

 

The Company has not entered into any off-balance sheet arrangements.

 

Key Business Risks and Uncertainties

 

Dependence Upon Key Personnel – The Company depends
on its senior management and technical staff. If the Company is unable to attract and retain key personnel, it may have a material
adverse effect on the Company. In an effort to manage this risk, the Company is establishing a competitive compensation grid for
all staff that includes certain benefits and stock options. The Company will be benchmarking its rates of pay to similar companies
and the compensation package that would normally be offered to senior individuals within the industry.

 

Technology Development – Delays in either technology
development or the transition to large scale application of the technology may cause a material adverse effect to the Company.
Technology development in the Company follows a strict path of concept, research, business analysis, design, beta testing and technical
implementation. These milestones are reviewed regularly with the head of technology development to ensure timely completion of
the technological milestones.

 

Financial Liquidity –The Company has not earned profits,
so its ability to finance operations is chiefly dependent on equity financings. While the Company has been successful in raising
equity financing in the past to support the POET initiative, there are no assurances that the Company will be able to continue
to raise further equity financing on favourable terms or at all.

 

Ability to Reach Profitability – The Company has no
history of profitability and may not be able to monetize POET.

 

Market Acceptance of New Products – The Company’s
POET technology is a new technology which currently does not have an installed base and may not be embraced for use by the semiconductor
industry. Branding is a key to creating market acceptance. There is no assurance that these risks can be mitigated through public
announcements, demonstrations and advertisements about the competitive advantage of the Company’s high efficiency technology.

 

Technology Changes – The Company's technology is highly
reliant upon staying ahead of technological changes, particularly in other competing semiconductor processes. If the Company cannot
keep pace, it may have a material adverse effect on the Company. Retaining qualified engineers and scientists has been identified
as a key success driver for the Company. Qualified personnel will continue to ensure that the Company is not only keeping in touch
with technological developments but is also implementing these new developments as appropriate.

 

Major Competitors – The Company may face several competitors
before or after it brings its technology to market which could result in the lack of acceptance thereby having a material adverse
effect on the Company. Through research and competitive data, the Company feels that these markets are ready for a new entrant
especially with the efficiency of the POET technology. Staying ahead of the curve with R&D, and consistency in process development
and technology transfer will be key to developing, keeping and maintaining industry share.

 

    	 	13	 

    

    

Please refer to the Company's Annual Information Forms filed on
SEDAR for a detailed discussion of Risk and Uncertainties.

 

Additional Information

 

Additional information relating to the Company is available on SEDAR
at www.sedar.com including the information contained in the Company's Annual Information Forms filed on SEDAR.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	14	 

    

    

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

		POET
                                         TECHNOLOGIES INC.

        Suite
        501, 121 Richmond St. W.      2550 Zanker Road

        Toronto,
        Ontario M5H 2K1    San Jose, CA 95131 USA

        Tel: 416-368-9411     -    
        Fax: 416-861-0749

        http://www.poet-technologies.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]